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Section I : Introduction
At the outset of this thesis, it should be 
mentioned that the trivial names of steroids will be 
used throughout. In Section VIII the steroids are 
listed in the order of their Homan numeral, giving 
their chemical nomenclature, the common name used in 
this thesis and the chemical formula.
Great steps have been made in recent years
towards the elucidation of the pathways of steroid
hormone biosynthesis. The first step may be said to
have been taken by Bloch (1945) when he demonstrated
that deuteri0 cholesterol (I) administered to a
0*1 <2.pregnant woman gave rise to isotopic pregn"4**eHe^  
5aî20u**diol (prognanedio 1, XXVII) in the urine , assumed 
to be derived via pregn-4-*ene-5î20**dione (progesterone, 
II) * Then in 1951 the first scheme of steroid hormone 
biosynthesis was published (Hechter et al., 1951).
The classical experiments of Hechter and his co*-- 
workers, in which the isolated oow adrenal was per­
fused with possible precursors and intermediates in 
the pathways of steroidogenesis and the steroid end 
products isolated and characterised, provided the 
basis of the now generally accepted scheme which is 
reproduced in Fig. 1.1.
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Fig. I.l, Synthesis of cortioosteroids in the 
adrenal cortex*
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The present knowledge of the pathways of 
biosynthesis has been extensively reviewed (Lieberman 
and Teich, 1955; Dorfman, 1957; Pincus, 1958; Dorfman, 
1958; Marrian, 1958; Grant, 1958; Short, 1958;
Katzman et al., 1959)• In the present discussion it is 
proposed to deal briefly with the biosynthesis of the 
corticosteroids, progesterone (II), the androgens and 
the oestrogens in turn*
The following discussion has been limited 
to animal transformations # The hydroxylation of the 
steroid molecule by many microorganisms at several 
different carbon atoms, as found by Murray and 
Peterson (1952) has proved of vast importance in the 
pharmaceutical industry, as well as providing a ready 
method of studying the mechanism of the reactions.
This latter aspect has been reviewed by Eppstein et al. 
(1956).
From the early work on the biosynthesis of 
the corticosteroids, by perfusion of the adrenal and 
incubation of adrenal tissue slices and homogenates 
with ^^ G-labelled precursors, it has been shown that 
the key intermediate is progesterone (II). Several 
enzyme systems are present in the adrenal to oxidise 
progesterone (II) at different carbon atoms, yield­
ing the main secretory products of the adrenal. These 
hydro3sylating enzymes are 17«"hydroxylase $ 21-hydroxy­
lase . llp-hydroxylase and 18-oxidase. In Fig* 1.1,
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the biosynthesis of the cortioosteroids from progester­
one (II) is shovm* The chemical nomenclature of the 
steroids shown in the figure is 21-hydroxypregn-4- 
ene-5:20-dione (deoxycorticosterone, III), lip:21- 
dihydroxypregn-4-ene-3î20-dione (corticosterone, IV) 
21-hydroxypregn-4-ene-3•11:20-trione (11-dehydro- 
corticosterone, IVa) ,, IIP ; 21-dihydroxy-5:20-dioxo- 
pregn-4-en-18-al (aldosterone, V), 17a-hydroxypregn- 
4-ene-5 :20-dione ( 17<x-hydroxyprogesterone, VI) ,
I7cc 121-dihydroxypregn-4-one-5 *20-dione (11-deoxy- 
cortisol, VII), lip:17ûÈî21-trihydroxypregn-4-ene-3î20- 
dione (cortisol, VIII), 17«s21-dihydroxypregn-4-ene- 
3:ll:20-trione (cortisone, IX), llp-hydroxypregn-4- 
ene-3Î20-dione (llp-hydroxyprogesterone, X), 3P“ 
hydroxypregn-5"en-20-one (pregnenolone, XI), 3p-hydroxy- 
androst-5-en-17-one (dehydroepiandrosterone, XIII) and 
3P Î17a-dihydroxy-pregn-3"On-20-one ( lYoc-hydroxypregn- 
enolone, XVII).. Dorfman (1957), in a very detailed 
review, tabulates the different systems employed in 
vjhich acetate, progesterone (II), cholesterol (I) and 
other compounds give rise to corticosteroids.
if
The pathway by which progesterone (II) is 
synthesised in endocrine organs has been investigated.
The immediate precursor appears to be pregnenolone (XI) 
because this compound readily gives rise to progester­
one (II) in various adrenal preparations (Hechter et al.,
4..
1951; Levy et al*., 1954î Samuels, 1955). Staple and 
Ms co-workers (1956) isolated pregnenolone (XI) and 
isooaproic aoid arising from the scission of the side 
chain of cholesterol between carbon atoms 20 and 22, 
thus confirming and expanding the belief that pregn­
enolone (XI) is formed by the degradation of the side 
chain of cholesterol (I) (Hayano et al.. 1956; Saba and 
Hechter, 1955).. 20p-Hydroxycholeaterol (XII) has been 
isolated as a radioactive product of the incubation of 
[4-i g^] cholesterol (I) with a bovine adrenal homogenate 
(Solomon, 1955), an observation which suggests that 
20p-hydroxycholesterol (XII) is an intermediate in the 
pathway between cholesterol (I) and pregnenolone (XI)., 
The synthesis of cholesterol from acetate 
has been well established and the mechanisms of the 
reactions involved have been studied in detail (Bloch, 
1958; Giba Foundation Colloquium, 1959). However 
several workers have put forth evidence in support of 
the view that cholesterol is not an obligatory inter­
mediate in the biosynthesis of steroids (Zaffaroni 
et al.. 1951; Hechter et al.. 1954; Stone and Hechter, 
1954). Perhaps the most striking evidence is that 
of Heard and his co-workers (1956) who found no radio­
activity in cholesterol (I) when a cell-free hog 
adrenal preparation was incubated with ^^ G-aoetate 
although cortisol (Till), corticosterone (IT) and
5.
other cortioosteroids showed significant radioactivity. 
However, although a pathway of steroid biosynthesis 
has thus been indicated without cholesterol (I) as an 
intermediate, nothing is known of the relative partici­
pation of the two pathways.
In a study of the biosyn-thesis of the 
androgens, three endocrine organs must be examined 
namely the adrenal, the testis and the ovary. That the 
adrenal synthesises androgens in vitro has been estab­
lished for some years (Kushinsky, 1955: Cooper et al., 
1955; Touchstone et al.. 1955; Bligh et al., 1955, 
Bloch et al.. 1956h, 1956b; Heard et al., 1956;
Rao and Heard, 1957). These conclusions have been 
confirmed by the presence of the androgens dehydro­
epiandrosterone (XIII), androst-4-ene-3:17-dione 
(androstenedione, XIV) and 11p-hydroxyandrost-4-ene- 
3 :17-dione ( 11 p-andro st enedione, XV) in adrenal 
effluent plasma» Although this in itself is not 
evidence for adrenal androgen synthesis, a comparison 
of the concentration of these three steroids in 
peripheral blood and in adrenal blood shows that the 
latter is much greater, thus indicating secretion of 
the androgens by the adrenal. The results of the 
in vitro studies with adrenal preparations pre­
viously referred to, and of in vitro studies with 
testicular preparations (Brady, 1951; Savard et al..
6.
1952; Wotiz et al.% 1955; Lynn, 1956; Lynn and Brown, 
1956; Slaimwliite and Samuels, 1956; Savard et al..
1956a, 1956b) indicate that a common pathway of androgen 
biosynthesis exists in these endocrine tissues. This 
scheme is shown in Fig. 1.2. There is evidence that 
the ovary synthesises androgen by the same pathway 
(Solomon et al., 1956). A more comprehensive discussion 
of androgen biosynthesis by ovarian tissue will be 
found in Section III. Dehydroepiandrosterone (XIII), 
which has not been shown in gonadal tissue, has been 
shown to arise in a homogenate prepared from human 
adrenocortical adenoma tissue by a pathway involving 
pregnenolone (XI) and 17a-hydroxypregnenolone (XVII) 
with subsequent scission of the side chain to dehydro­
epiandrosterone (XIII), rather than directly from 
cholesterol (I) (Goldstein et al,# 1958).
In addition androgens may arise from the 
splitting of the side chain of certain Ggi steroids.
In this way androstenedione (XIV) is the result of the 
action of a suitable desmolase on 17u-hydroxypr0- 
gesterone (Vl) or 11-deoxycortisol (VII). Similarly 
11p-hydroxyandroatenedione (XV) is formed from 
cortisol (VIII) and androst-4-ene-3îIIî17-trione 
(adrenosterone, XVIII) from cortisone (IX). This is 
a peripheral mechanism, demonstrable to only a slight 
extent and thought to reside mainly in the liver
ACETATE
GH0LE8TEE01(I)
V
PREGMENOLOHE(XI)
PROGESTERONE(II)
GH
GO
L - OH
0
17 a-HIDROXÏPHOGESTEROîîE (VI) 
0
MDROSÎEREDIOm(XIV) 17P-HXDR0XX- 
AroROST-4"ER-3-OHE 
(TESTOSIERORE, XVI)
Eig# 1*2. Synthesis of androgens in endocrine 
glands.
7.
(Forchielli et al* * 1955 ; Forchlelll and Dorfman, 1956)* 
For some years it has been shown that the 0,9 
steroids give rise to oestrogens both in vitro, with 
ovarian and placental slices (Meyer, 1955; Baggett 
et al», 1956; Wotis et al#,1956), and in vivo after 
the administration of androgens to a pregnant mare 
(Heard et al.» ^ 1955) and to adrenalectomised-ovari™ 
eotomised women (lest et al#, 1956)* Recently the work 
of Ryan (1959 # I960) has extended the Imowledge regard­
ing the biosynthesis of the oestrogens, 3-hydroxyoestra- 
lî3:5(10)-trien-17-*one (oestrone, XIX), oestra-1:3î5(10)- 
triene-3Î17P^diol (oestradiol-17P, XX) and oestra- 
1:3!5(10)-triene-3îl6aïl7P-triol (oestriol, XXI)#
Ryan’s system is a microsomal preparation from human 
placenta which in the presence of reduced triphos- 
phopyridlne nucleotide (TFNH) or a IPKH generating 
system, converts androstenedione (XIV) and related 
androgens to oestrogens. By comparing the relative 
efficiency of the substrates used as precursors of 
oestrogen, Ryan has obtained results from which he 
has been able to postulate that aromatisation of the 
0,9 steroids proceeds via 0-19 hydroxylation*. Because 
19-nortestosterone (XXII) and androsta-1:4-dlene- 
3:17-dione (XXIII) are converted to oestrogens much 
less efficiently than 19-hydroxyandrost-4-ene-3:17- 
dione (19-hydroxyandrostenedlone, XXIV) or Indeed
8*
than androstenedione (XIV) or testosterone (XVI), Ryan 
suggests that the G-19 hydroxylation is followed by 
the introduction of a double bond simultaneously or 
nearly so with the removal of the angular group at 
G-19. Complete elucidation of the mechanism of the 
aromatisation of the G,9 steroids to yield steroids 
is awaited with great interest.
This thesis presents the results of in vitro
incubations of tissue slices of Stein-Levanthal ovaries
and of a feminising adrenal tumour. Slices of Stein-
Leventhal ovaries were incubated with [l-’+G„ acetate
and the steroids elaborated were studied using the
reverse isotope dilution technique. Because of the
nature of the Stein-Levanthal syndrome, in which the
o
hirsutism and amenorrhjea suggests an excessive pro­
duction of androgens, interest was focussed on the 
ability of the ovaries to synthesise androgens and 
oestrogens. Evidence will be presented for the 
biosynthesis of oestrone (XIX), oestradiol (XX), 
testosterone (XVI), androstenedione (XIV), 17cc- 
hydroxyprogesterone (VI) and progesterone (II) from
l-’^ o] acetate by tissue slices of Stein-Levanthal 
ovaries.
Section IV deals with the incubation of 
slices of a feminising adrenal tumour with [l-’^ o] 
acetate and progesterone. Little is known of
the capability of this rare type of tumour to synthesise
9.
steroid hormones# Accordingly the steroids elaborated 
were diluted with oestrogens, androgens, cortioosteroids 
and progesterone (II) to obtain, from a study of these 
compounds an overall picture of the biosynthetic 
potential* Evidence will be presented for the synthesis 
of progesterone (II), cortisol (VIII), androstenedione 
(XIV) and 17a-hydroxyprogesterone (VI) from l-’^ cj 
acetate by slices of the feminising adrenal tumour.
In addition the results indicate the conversion of 
[4.-14.0 progesterone to cortisol (VIII), androstenedione 
(XIV), 17(%-hydro%yprogesterone (VI), corticosterone (IV) 
and 11-deoxycortisol (VII) by slices of the tumour.
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Section XI ; Materials and Methods
Reap;ents and materials.
Methanol and ethanol were purohased from 
Burroughs Wellcome Ltd. (AH grade). All other solvents 
were purchased from British Drug Houses Ltd. (AH grade). 
All solvents were distilled before use.
Diethyl ether was rendered peroxide-free by 
being shaken with a saturated aqueous solution of 
ferrous sulphate and then distilled immediately before 
use. Peroxide-free ether was used throughout the work 
being presented.
Glacial acetic acid was purified by being 
refluxed with potassium permanganate for 50 mins. and 
then distilled.
Acetic anhydride was purified by distilla­
tion from fused sodium acetate.
Pyridine was dried by being refluxed with 
and then distilled from anhydrous barium oxide. It 
was stored over sodium hydroxide pellets.
Trimethylacethydraside ammonium chloride 
(Girard’s Reagent T) was purchased from British Drug 
Houses Ltd. The reagent was recrystallised from 
ethanol.
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Digitonin was purchased from British Drug 
Houses Ltd.
Human menopausal gonadotrophin (HîvïG) was 
donated by Dr. 0. L. Hewett of Organon Laboratories Ltd* 
and was quoted by them as having an activity of 1 unit 
per mg.
Adrenocortiootrophic hormone (AOTH) was pur­
chased from Armour Laboratories.
Adenosine triphosphate (ATP) and triphos- 
phopyridine nucleotide (TPH) were purchased from 
nutritional Biochemicals Corp., Ohio, U.S.A.
Progesterone (II) and sodium l-’^ o] 
acetate were purchased from the Radiochemical Centre, 
Amersham, England*
Oestrone (XIX), oestradiol-17p (XX) and 
oestriol (XXI), androstendione (XIV) and cortisol (VIII) 
used in the experiments with the feminising tumour of 
the adrenal, were kindly gifted by Dr* 0. L. Hewett of 
Organqn Laboratories Ltd. Androstenedione (XIV), 
3a-hydroxy-5oc-androstan-17-one (androsterone, XXV), 
lla-hydroxyprogesterone (VI), progesterone (II) and 
testosterone (XVI) which were used in the study of the 
Stein-Leventhal ovaries were kindly donated by Dr. W. 
Klyne of the Medical Research Council, London.
17oc-Hydroxyprogesterone (VI), corticosterone (IV), and 
11-deoxycortisol (VII) which were used in the study of 
the feminising adrenal tumour were purchased from
12.
Main Hesearoli Laboratories, Inc., Hew York. Dehydro­
epiandrosterone (XIII) was purchased from Thomson, 
Skinner and Hamilton Ltd., Glasgow.
Melting-point Determinations
Melting points were determined on a hot stage 
apparatus (Gellenkamp, England), using the same thermom­
eter throughout* The recorded melting points are 
uncorrected for the emergent stem.
Assay of Radioactivity
Radioactivity was determined in a windowless
pas -F/o uj
flow—gas- counter (Tracerlab, Inc.) operating at about 
50% efficiency for ’^ 0. The planchettes used were 
copper plates (2*5 cm, diameter) which were cleaned by 
dipping into chromic acid solution for a few seconds, 
followed by thorough washing in tap water, distilled 
water, alcohol and ether. The plates were finally dried 
in air. Samples of material to be assayed were dis­
pensed from methanolio solutions. Plates were counted 
at infinite thinness for a sufficient length of time to 
give a counting error of less than 5%.
Specific activities throughout are expressed 
as counts per minute (cpm) per mg. Where derivatives 
have been formed, specific activities have been calcu­
lated as cpm per mg. free compound.
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Concentration of Solutions.
Removal of solvents from extracts was carried 
out by distillation in vacuo on a water bath at a tem­
perature not exceeding 45°.
Small volumes of solvents from extracts were 
evaporated under a stream of nitrogen, on a water bath 
at temperatures below 45°.
Paper Chromatography.
Before chromatography Whatman No. 1 chromato­
graphy paper was washed by allowing methanol to flow 
down it for 24 hours in a chromatography tank* The 
paper was dried in air.
The toluene-propylene glycol solvent system 
(Zaffaroni and Burton, 1951) and the ligroin-propylene 
glycol solvent system (Savard, 1953) were used to 
separate mixtures of steroids on paper. Androstenedione 
(XIV), IToc-hydroxyprogesterone (VI), testosterone (XVI), 
progesterone (II), cortisol (VIII), corticosterone (IV),
11-deoxyoortisol (VII) and deoxycorticosterone (III) 
were detected on paper by their absorption of uv light 
(maximum l^âtsmission, 253.7 mp). Androsterone (XXV), 
dehydroepiandrosterone (XIII) and oestrone (XIX) were 
detected by the modification of the Zimmermann reaction 
described by Savard (1953). The Folin-Giocaltej^ u
14.
reagent as used by Layne and Marrian (1958) detected 
oestradiol (XX) and oestriol (XXI),
Steroids were eluted from the paper with 
methanol (5-10 ml,).
Measurement of Steroids.
The concentration of a methanolio solution 
of a /\^ -3 ketosteroid was determined from the absorp­
tion maximum at or about 240 mp, that of an oestrogen 
from the maximum at or about 280 mp and that of the 
oestrogen acetates from the maxima at 267 m p and 275 m p. 
The concentration is calculated from the equation
E 0 = X
where E is the molar extinction coefficient of the 
solute for the particular wavelength in question, c is 
the oono entrât ion of the solute in g. mole«, per litre 
and K is the extinction coefficient, equal to the optical 
density when the light path of the solution is 1 cm. 
Optical densities were measured using a spectrophoto­
meter (Unicam, Model SP. 500) and cells of 1 cm. light 
path. The following values were determined with 
solutions of authentic samples in methanol.
15.
WeOH c
Steroid /\ max (mp. )
c
oestrone (XIX) 280 2129
oestrone monoacetate 1* 266 759
2# 275 704
oestradiol (XX) 280 2047
oestriol (XXI) 280 2158
oestriol triacetate 1# 268 842
2# 275 761
cortisol (VIII) 240 15900
cortisol 21-monoacetate 240 16900
ll**deoxyoortisol (VII) 240 15700
deoxycorticosterone (III) 240 17410
corticosterone (IV) 240 15600
progesterone (II) 240 16500
17a-hydr03Qrprogesterone (VI) 240 16400
androstenedione (XIV) 240 15700
testosterone (XVI) 240 15600
testosterone monoacetate 240 19700
Dehydroepiandrosterone (XIII) was estimated 
by the method of Oertel and lik-Nes (1959)*
Preparation of Acetates*
When less than 1 mg* material was available 
for acétylation, the material was dissolved in 0.4 ml# 
dry pyridine and 0*2 ml# acetic anhydride was added#
16.
The réaction was allowed to px^ oceed at room temperature 
for 18 hours, then stopped by the addition of a few drops 
of methanol. The reaction mixture was evaporated to 
dryness under nitrogen.
The same procedure, using 2 volumes pyridine 
to 1 volume acetic anhydride was followed when more 
than 1 mg. material was available for acétylation. The 
reaction was stopped by adding the reaction mixture 
dropwise to water (50 ml.). The acetate derivative was 
extracted with ether (2 x 50 ml., 2 x 25 ml.) and the 
ether phase washed with H HOI (3 x 1/10 vol.), water 
(3 X 1/10 vol.), 5% (w/v) NagOO  ^(3 x 1/10 vol.) and 
water to neutrality. The ethereal solution of the 
acetate was evaporated to dryness.
Hydrolysis of oestradiol diacetate.
Oestradiol diacetate was hydrolysed by re- 
fluxing with 5% (w/v) KOH in 80% (v/v) ethanol (1 ml. 
per mg. oestradiol diacetate) for 2 hours. After 
acidification, the oestradiol (XY) was extracted with 
ether. The ether was washed with water till no longer 
acid and evaporated to dryness*
Preparation of androstenedlone-bis-dinitrophenylhydra- 
gone.
iVndrostenedione-bis-dinitrophenylhydrazone 
was prepared by Method A of Reich et al.. (1953)•
17.
In this method excess dinitrophenylhydraaine is dis­
charged by the addition of Benedict’s reagent and the 
steroid-BHP extracted into chlox'oform. The x*esidue 
obtained by evaporation of the chloroform extract was 
further purified on a column of silica gel, the andro- 
stenedione-bis-MP being eluted from the column partially 
by benzene and totally by 1% (v/v) ethyl acetate in 
benzene.
Hydrolysis of androstenedione-bis-DHP.
The androstenedione-bis-MP (9 mg.) was dis­
solved in chloroform ( 4 ml.). Concentrated HOI (3 ml.) 
was added together with sufficient ethanol (6 ml.) to 
produce a homogeneous mixture. The mixture was refluxed 
for 5 hours, then diluted with water (100 ml.). The 
product was extracted with ether and the ether solution 
washed with 2H HOI (3 x 1/10 vol.), then water till no 
longer acid. The ethereal solution was evaporated to 
dryness and the androstenedione was purified by paper 
chromatography.
Sulphuric acid Ghromogens.
To thoroughly dried steroid (10-60 pg.) 3 ml. 
concentx'ated HgSO^  was added. After 2 hours at room 
temperature, the spectrum of the sulphuric acid chromo­
gen was read over the range 200 mp to 600 mji . For
18,
reference, the spectra of the sulphuric acid chromogens 
of several authentic steroids are reported in Table 
II* 1. The notation is that of Bernstein and Lenhard 
(1953). An. absorption band is designated by a single 
wavelength* The symbol [ij denotes an inflection or 
plateau, represented by a single wavelength* The same 
system is used throughout this thesis*
Table II. 1. Sulphuric- acid chromogen maxima and
minima of authentic steroids.
STEROID OOHOH. 
in 3 ml. 
oonc.
H3SO4
MAXIMA 
mp (O.D.)
MINIMA 
mp (O.D.)
oestrone
(XIX)
48.5 |1S* 232(.550) [I];
300(.844);
446(.578).
253(.146);
370(.041).
oestrone
acetate
104 jag.
(acetate)
232(.712) [I]}
300(1.038);
44B(.695).
252(.193)i
365(.048).
oestradiol
(XX)
51 jig. 278(.291); 
310(.310); 
367(1.005); 
424(.958);^ , 
442(.562) [ij.
260(.244);
288(.247);
318(.300);
390(.570).
oestriol
(XXI)
40 pg. 23K.342) [I];
305(.215);
452(.146).
263(.050);
331(.040).
oestriol
triacetate
. 91 Mg.
(acetate)
232(.460) [iJ; 
305(.301);
354(.108);
449(.110).
265(.116);
332(.092);
393(.070).
cortisol
(VIII)
41 jig. 232(.555) [I]; 
278(.560); 
392(.278); 
468(.355).
250(.575)5
340(.137);
412(.230).
cortisol
21-mono-
acetate
9.2 fig.
(acetate) 234(.121) [I];
284(.170);
392(.065).
253(.095);
360(.053).
11-deoxycortisol
21-môno-
acetate
. 17 jig. 
(acetate)
216(.142); 
238(.115) [I]; 
288(.259);^  ^
332(.090) [I]; 
538(.060).
248(.105);
420(.025).
Table II* 1* (ooiitdp)
STEROID
corticosterone
21**mono-
acetate
progesterone
X m
17 (% -hydroxy- 
progesterone
t m
OONOE* 
in 3 ml, 
cono# 
H2BO4
m x i m
mp (O.D*)
,870)t
,251,
61 pg.
(acetate) $
376(.1S6)} 
474(.169).
51 PS. 223(.36g); 
292(.960).
48 ug, 246(.302) [i]} 
288(,860); 
429(.510).
zap (O.D.)
235(.289)i 
322(.259)5 
366(.146)5 
406(.105).
233(.545).
255(.285);
335(.044).
androstenedlone 49.2 pg. 296(1.42). 237(.167).
19.
Section III : Inoubation of Stein-Leventhal ovaries
with sodiiam 1- ^ *0 acetate
I. Introduction*
The syndrome of large polycystic ovaries with
o
thickened capsules $ associated with hirsutism, amenorrb(ea 
and sterility was first described by Stein and Leventhal 
in 1935.
Opinions differ as to the origin of the andro­
gens bringing about the hirsutism in this syndrome. In 
many oases elevated urinary androsterone (XXV) and 
5a-hydroxy-5P-androstan-17-one (etiocholanolone, XXVI) 
with normal or slightly elevated dehydroepiandrosterone
(XIII) have been found. It is reported that these 
values are not significantly depressed on the admin­
istration of cortisone (Johnsen, 1956; Pesonen and 
Mikkonen, 1958). On the other hand Perloff (1957) 
and Gallagher and his co-workers (1958) maintain that 
the pattern of the urinary 17-ketosteroids is similar 
to that of idiopathic hirsutism in which excessive 
adrenal production of 11-deoxysteroids is indicated*
The levels are increased by AOTÏÏ and suppressed by 
corticosteroid in these oases* These observations 
certainly suggest the involvement of some preoursor(s) 
arising from the adrenal cortex* However, they do 
not explain the relief of the symptoms given by
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bilateral wedge resection of the ovaries. It is 
interesting to note the classification of Stein- 
Levanthal ovaries by Pesonen et al*. (1959). These 
authors list two main types, the first in which the 
ovaries are active although enlarged, and which they 
suggest is caused by a defect predominantly of ovarian 
origin, and the other in which there is an absence of 
signs of ovarian function and which is best interpreted 
as the result of the disorder of a gland other than 
the ovary, for example, the adrenal gland, hanthier 
(1960) apparently feels any such classification rather 
artificial, preferring to view the differing clinical 
findings as manifestations, in different degrees, of 
the same disorder of steroid metabolism, in which both 
the ovary and the adrenal are concerned.
Indirect evidence of androgen production by 
the ovary was given by Katsh (1950) v/ho demonstrated 
androgenic activity of ovarian transplants to the 
seminal vesicle of castrated male rats. Further evi­
dence came from the work of Solomon et al.. (1956) who 
showed the conversion of progesterone (II) to l?ct- 
hydroxyprogesterone (VI) and androstenedione (XIV) by 
a bovine ovarian homogenate. The isolation of these 
two steroids from extracts of human ovaries (Zander, 
1958) has strengthened the theory that the ovary is 
capable of synthesising androgens*
Several workers have reported the synthesis
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of oestrogens by ovarian tissue in vitro. The con­
version by human ovarian tissue slices of 
testosterone to ‘^♦G-oestradiol-17P (Baggett et al. $
1956) and to  ^*0-oestradiol-17!3, '^*0-oestrone and  ^^G- 
oestriol (Wotis et al., 1956) has been demonstrated..
The conversion of '^ G-aoetate to oestrone and oestradiol* 
17P has been shown in ovarian systems both by a dog 
ovarian homogenate (Rabinowitz and Dov/ben, 1953) and by 
perfusion of sow ovaries (Werthessen, 1953)*
The following work presents evidence for the 
synthesis of progesterone, oestrogens and androgens 
from sodium [i-^ g^] acetate by in vitro incubations of 
St0in-Bevanthal ovaries.
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2a. Incubation Qondltlons.
Ovarian tissue was obtained from women with 
the St0in-Levanthal syndrome undergoing bilateral wedge 
resection of the ovaries. About an hour elapsed be­
tween removal of the tissue and the start of the in­
cubation period. The tissue was sliced by hand with a 
Stadie-Riggs microtome and incubated for 2-1/2 hours at 
37° 0 with continuous shaking in an atmosphere of 
oxygen in Krebs-Ringer phosphate buffer (pH 7*4) con­
taining sodium [l-^ o^] acetate (0.01 M, specific 
activity 2 juc/mg*), glucose (0.01 M), nicotinamide 
(0.04 M) and fumarate (0,01 M). In two incubations 
human menopausal gonadotrophin (HMG, 1 unit per mg.) 
was added. The Incubations were
I. (M,0*D); 2.7 -g. slices in 20 ml. buffer with
5 mg. mua. -
lia. (H.McA. left side): 5.31 g. slices in 15 ml.
buffer with 5 mg. fflîG.
Ilb. (H.McA. right side); 5.22 g. slices in 15 ml.
buffer without HflG.
2b. Extraction.
The procedure was identical in all three 
incubations. The tissue and the incubation medium were 
separated and the incubation medium was extracted with 
ethyl acetate (6 x equal volume). The tissue was
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homogenised in water (20 ml.) and this homogenate ex­
tracted with ethyl acetate (6 x 20 ml*). The ethyl 
acetate extracts were combined and evaporated to dryness.
The crude extract was dissolved in heptane 
(30 ml.), and extracted 4 times with 90% aqueous methanol 
(60 ml. portions). The heptane fraction and the aqueous 
methanol fractions were taken to dryness and assayed 
for radioactivity.
(B-Sterol Fraction
The p-sterol fraction (mainly cholesterol) of 
the heptane phase was precipitated as the digitonide.
A solution of digitonin (5 x weight of the heptane 
fraction, concentration of 10 mg./ml.) in hot 80% (v/v) 
aqueous ethanol was added to the heptane fraction dis­
solved in hot ethanol (10 mg./ml.)* The digitonide 
formed was washed with acetone î ether (1:1, v/v) and 
then with ether.
The digitonide was cleaved to give a p- 
sterol fraction (cholesterol) by heating in dry pyridine 
at 70-80^  G for 30 minutes (Bergmann, 1940). The 
pyridine was evaporated and the cholesterol isolated 
by extracting the residue with ether. The specific 
activity of the cholesterol was determined.
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Phenolic Extraction.
The residue from the 90% methanol fraction 
was dissolved in toluene (100 ml.). The toluene solu­
tion was extracted 5 times with N NaOH (25 ml. portions), 
then with water to neutrality and evaporated to dryness. 
This residue contained the neutral steroids.
The comhined alkali and aqueous phases were 
acidified with conc. HOI and extracted 6 times with 
ether (50 ml. portions). The combined ether extracts 
were washed with water to neutrality and evaporated to 
dryness. The residue obtained contained the phenolic 
steroids.
Separation of an *Oestriol* Fraction
The phenolic residue was separated into an 
*oestrone-oestradiol* fraction and an *oestriol* frac­
tion by the method of Friedgood et al.. (1948). The 
phenolic fraction dissolved jn benzene (100 ml.) was 
extracted 3 times with a solution of 0,075 M NagHPO^
(50 ml. portions). The benzene residue (the *oestrone- 
oestradiol* fraction) was evaporated to dryness.
The aqueous phase was taken to pH 2 by the 
addition of dilute H2SO4 and extracted 4 times with 
ether (75 ml. portions). The ethereal extract was 
washed with water to neutrality and evaporated to dry­
ness. The material obtained was the ’oestriol* fraction.
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i;ion of an ’oestrone* fraction.
An ’oestrone’ fraction v/as obtained by the 
micro-Gix'ard separation described by Plnous and Pearlman 
(1941)* Glacial acetic acid (2 ml.) and Girard’s 
Reagent T (400 mg.) were added to the ’oestrone- 
oestradiol* fraction and the reaction mixture was re­
fluxed for 30 minutes under anhydrous conditions.
After cooling, the contents were added to ice-cold 
0*45 R RaOH (75 ml.) and the pH adjusted to between 6*7 
and 7.0. The mixture was extracted 4 times with ether 
(50 ml. portions). The ether was washed with ice-cold 
water (20 ml.), 2.5% (w/v) (20 ml.) and water
to neutrality. The initial water wash was added to 
the aqueous phase, the other washes being discarded.
The ether, containing the non-ketonic ’oestradiol* 
fraction, was evaporated to dryness.
The aqueous phase was adjusted to pH 1 with 
concentrated HOI and allowed to hydrolyse at room 
temperature for 2 hours, and extracted 4 times with 
ether (50 ml. pointions). The ether phase after being 
washed with 2.5% (w/v) NagOO^ j (20 ml.) and water to 
neutrality, was evaporated to dryness. The material 
obtained was the ketonic ’oestrone* fraction.
A sumiiiary of the extraction procedure is given 
schematically in Fig. III.l* At each stage of the ex­
traction, the radioactivity assays were done.
mOüBATÏOH
TISSUE
Homogenised in water;
Extracted with etliyl 
acetate.
Extracted with ethyl 
acetate*
ETHYL ACETATE
HEPTAHE
FRACTION
Digitonin
CHOLESTEROL
Heptane - 90% methanol*.
90% METEâHOL 
FRACTION
Toluene - N NaOH*
NEUTRALS PHENOLS- 
ACIDS
Benzene-
NagHPO*
♦OESTRONE- ’OESTRIOL *
OESTRADIOL* FRACTION
FRACTION
Girard’s Reagent T,
1
’OESTRONE’
FRACTION
’OESTRADIOL’
FRACTION
Fig* 111*1, Extraction and Purification Procedure*
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The Oestrogens*
The oestrogen fractions were each diluted 
with the respective carrier and purified by repeated 
crystallisations. The melting point and the specific 
activity of each crop of crystals were determined.
Unfortimately the ’oestradiol’ and ’oestriol' fractions 
of Experiment I were lost* The amounts of carrier 
added are shown in Table III.l,
In experiment Ila it was found that two crys­
tallisations from aqueous methanol of the oestradiol- 
17P (XX) separated the radioactivity from the crystal­
line material. The mother liquor from the first crys­
tallisation was then acetylated, the product being 
crystallised twice. The oestradiol diacetate was 
hydrolysed and the product crystallised three times 
from aqueous methanol. In Experiment lib after addi­
tion of carrier oestradiol-17P (XX) to the ’oestradiol* 
fraction, the mixture was immediately acetylated, the 
product being crystallised, then hydrolysed.. The free 
oestradiol-17P (XX) was crystallised from aqueous 
methanol.
The Neutral Steroids.
The neutral fractions obtained from experi­
ments Ila and lib were chromatographed on paper for 48 
hours (solvent system, ligroin-propylene glycol). To
Table III. 1. Addition of the respective carrier to
each radioactive oestrogen fraction*
Experiment I Ila lib
'Oestrone'
0pm* 1700 280 130
. carrier oestrone (mg.) 8*24 6*20 6.08
'Oestradiol'
0pm. - 6075 1300
Wt* carrier oestradlol-17p 
(mg.) 25*95 10*85
'Oestriol*
0pm. - 970 1350
Wt. carrier oestriol (mg*) 5*10 5*00
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the overflow a mixture of androsterone (XXV, 56 pg.) , 
androstenedione (XIV, 49 pg.) and progesterone (II,
46.5 pg.) was added. These steroids were resolved by 
paper ohromatography in the solvent system ligro in­
propylene glycol. The original chromatogram was eluted 
and a mixture of testosterone (XVI, 54.5 pg.) and 17a- 
hydroxyprogesterone (VI, 52.4 pg.) was added to the 
eluate* However these steroids do not separate in the 
ligroin-propylene glycol system,
Additional carrier material was added to each 
steroid fraction in the following amounts; androsterone 
(XXV, 305 pg.), androstenedione, (XIV, 350 pg.), 
progesterone (II, 279 pg.), testosterone (XVI, 182 pg.) 
and 17a-hydroxyprogesterone (VI, 237 pg.). The mixture 
of testosterone (XVI) and 17a-hydroxyprogesterone (VI) 
was separated after acétylation, testosterone acetate 
having a much greater mobility than 17a-hydroxyprogester­
one (VI) in the ligroin-propylene glycol solvent system. 
Each steroid was purified by successive chromatography 
on paper, the specific activities of the eluted materi­
als being measured at each stage.
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3. Results
At every stage of the extraction procedure 
the radioactivity in eaoh fraction was assayed. The 
results obtained, expressed as opm and as percentage 
incorporation of the ’^ 0-aoetate precursor, are shown 
in Table III.2. It is evident that there was consider­
able variation from one experiment to another.
Cholesterol (I)
The cholesterol isolated from each experiment 
was found to be radioactive. In Experiment I the heptane 
fraction of specific activity 950 opm per mg. yielded 
cholesterol, specific activity 1190 cpm per mg. The 
heptane fraction, specific activity 9400 cpm per mg., 
of the Experiment Ila gave cholesterol of specific 
activity 10,000 cpm per mg. The heptane fraction, 
specific activity 7200 opm per mg., of Experiments .
Ilb yielded cholesterol of specific activity 12,000 
opm per mg.
Oestrone (XIX)
Experiment I
8.24 mg. of oestrone was added to the 
’oestrone* fraction (1700 cpm) giving a total weight 
of 9.01 mg. of material of specific activity 189 cpm 
per mg. The material was recrystallised twice from
Table III, 2*. Counts per minute and percentage
incorporation of sodium |l-* ^o] acetate 
in eaoh fraction of the extraction 
procedure.
Experiment I
Sodium [l-* * ^o] 3 *-6 x 10*?
acetate opm
incubated#
Ila
3,9 % 10? 
opm
Ilb
3,9 X 10? 
cpm
FRAOriGK; Opm $age
conver­
sion
Opm %age
conver­
sion
Opm '$age
oonver
sion
Hepliane 9500 0.027 76400 0.20 81200 0,21
90$ methanol 10.60X 
106
29.7 2,25 X 
106
5.8 1.79 X 
10®
4.6
Neutrals 18500 0,052 15800 0.41 111000 0.28
Phenols-
Acids
42000 0.118 7000 0,018 8900 0.023
'Oestriol' 31500 0.088 970 0.0025 1350 0,003
'Oestrone- 
Oestradiol'
7500 0.021 7770 0.020 1850 0.005
'Oestrone' 1700 0.005 280 0,0007 130 0.0003
'Oestradiol* 4900 0.014 6075 0.016 1300 0.003
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aqueous methanol* The results obtained from melting 
point determinations of crystals and specific activity 
determinations of crystals and mother liquor are shown 
in Table III.3* The final material, m.p* 254-256°, 
had a specific activity of 132 cpm per mg. This rep­
resents a minimum incorporation of [l-’^ o] acetate of 
0.003% into oestrone*
Experiment Ila
6*20 mg. of oestrone was added to the 
’oestrone’ fraction (280 cpm) giving a total weight 
of 6*82 mg* of material, specific activity 41 opm per 
mg. Orystallisation from aqueous methanol yielded 
5,42 mg. of crystals (m.p* 248-253°), specific activity 
33 cpm per mg# This represents a minimum of 0.0006% 
incorporation of [l-’*Oj acetate into oestrone*
Experiment Ilb.
6*08 mg* of carrier was added to the 
'oestrone* fraction (130 cpm) giving 6*30 mg. of 
material, specific activity 20*6 opm per mg* Crys­
tallisation from aqueous methanol yielded 5*10 mg* of 
crystals (m.p* 247-253°) of specific activity 19*6.
The minimum incorporation of [l-’^ o] acetate into 
oestrone was 0.0003%.
Table III. 3. Orystallisation of oestrone in
Experiment I ; Specific activities 
(sp.act.) of crystals and mother 
liquors•
OHXSTALS MOTHER LIQUOR
Orystallisation Wt. M.p. Sp.act. Wt. Sp.act.
(mg.) (opm/mg.)(mg.) (opni/mg.)
5.51 238-244° 120 2.63 278
4.65 254-256° 132 0.76 175
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QestradiQl-170 (XZ)
Experiment Ila
25.95 mg. of oestradiol carrier was added to 
the crude fraction (6075 cpm) giving a total weight of
29.10 mg., specific activity 209 opm per mg. Two 
crystallisations separated the crystals from the radio­
activity. The results are shown in Table III.4*
The mother liquor from the first crystallisa­
tion was acetylated and the product crystallised twice 
from aqueous methanol, then hydrolysed. The reaction 
product was crystallised three times, finally yielding 
material (m.p. 168-172°) of specific activity 826 cpm 
per mg. If the possibility of additional ’'♦G-oestradiol 
diacetate being present in the mother liquor of the 
second crystallisation of oestradiol-17P (i.e. before 
acétylation) is ignored, this represents a minimum of 
0.014% conversion of l-’^ o] acetate to ’^ 0-oestradiol 
or ’^ 0-oestradiol diacetate. In the results summarised 
in Table III.5, the specific activities of the diacetate 
have been calculated as opm per mg. of free oestradiol- 
1713.
Expei'iment Ilb,
10.85 mg. oestradiol carrier was added to the 
’oestradiol* fraction (1300 cpm) giving a total weight 
of 11.70 mg. of material, specific activity 108 opm
Table III. 4. Crystallisation of oestradiol-17p in
Experiment Ila : SpeoifiG activities 
(sp.aot.) of crystals.
C R Y S T A L S
Crystallisation Wt. M.p. Sp.act*
) (opm/mg.)
22.00 170- 172° 39.6
13.43 174-177° 3.6
Table III# 5* Acétylation of oestradiol-lîp and
subsequent hydrolysis in Experiment Ila ; 
Specific activities (sp.act.) of 
products and crystals are calculated 
as cpm# per mg. free oestradiol-170 
in every instance.
Wt. M.p. Sp.act*
(mg.) (cpm/mg.)
Mother liquor 6.51 - 830
Acétylation Eroduot 6.55 “ 950
Crystallisation : 1 5.45 96-108° 638
2 4.70 115-117° 668
Hydrolysis Product 3.80 - 680
Crystallisation : 1 2.50 168-172° 778
2 1.70 168-172° 804
3 1.15 168-172° 826
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per mg. This material was acetylated and the product 
was crystallised from aqueous methanol, then hydrolysed. 
Orystallisation of the hydrolysis product from aqueous 
methanol yielded crystals of specific activity 89 opm 
per mg. This indicates a minimum of 0.003% incorpora­
tion of l-^ o^] acetate. The results are shown in 
Table III.6.
Experiment Ila.
5.10 mg. of oestriol was added to the crude 
•oestriol* fraction (970 cpm) giving 5*48 mg. of 
material, specific activity 190 opm per mg. Two 
crystallisations were performed from aqueous methanol 
but no constancy in specific activity was achieved.
The results are shown in Table III.7.
Experiment Ilb.
5.00 mg. of oestriol carrier was added to the 
’oestriol* fraction (1350 opm) giving a total weight 
of 5*55 mg. of material, specific activity 242 opm per 
mg. Crystallisation yielded 1.05 mg. of crystals 
(m.p. 260-264°) of specific activity 83 opm per mg.
Table III. 6. Acétylation of cestradio1-17P and
subsequent hydrolysis in Experiment lib : 
Specific activities (sp.act.) are 
calculated as opm per mg. free 
oestradiol-17P.
Wt. M.p. Sp.act.
(mg.) (cpm/mg.)
Acétylation Product 13.70 - 115
Crystallisation 12.50 119-121° 79
Hydrolysis and 3.70 168-172° 89
Crystallisation
Table III. 7* Orystallisation of oestriol in Experi­
ment lia ! Specific activities (sp.act.) 
of crystals.
Orystallisation Wt# M.p. Sp.act.
(mg.) (cpm/mg.)
3.09 264-266° 47
1.80 265-268° 22
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Neutral Steroids
After dilution with carrier, the steroids 
being studied, androsterone (XXV), androstenedione (XIV), 
progesterone (II), testosterone (XVI) and ITa-hydroxy- 
progesterone (VI) were further purified by chromato­
graphy on pape# (solvent system, ligroin-propylene 
glycol). Androsterone (XXV) proved to be only slightly 
radioactive and its study was not pursued. Androstenedi­
one (XIV), after three chromatograms, appeared to have 
constant specific activity (934 cpm per mg.) in Experi­
ment lib but no constancy was achieved in Experiment 
11$. After five chromatograms the specific activity 
of progesterone (II) was constant (1251 cpm per mg.) 
ill Experiment Ila but not so in Ilb. The specific 
activity of testosterone (XVI) was constant in Experi­
ment Ila after two paper chromatograms, 3034 cpm per 
mg. (calculated as free testosterone) and in Experi­
ment lib after four chromatograms, 1516 cpm per mg. 
(calculated as free testosterone). 17a-Hydroxypro- 
gesterone (VI) had constant specific activity in both 
6][periments after two chromatograms, 2640 cpm per mg. 
in Experiment Ila and 1028 cpm per mg. in Experiment 
lib. The specific activities of these steroids eluted 
from each chromatogram together with the percentage 
minimum incorporation of l-’^ o^] acetate into each 
steroid are given in Tables III.8-III.il inclusive.
Table III. 8. Specific activities (sp.aot.) of
androstenedione from successive
paper chromatograms.
Chromât o gram
Sp.act*(cpm/mg.) of 
andro s t ene di one
Experiment Ila Experiment Ilb
1055 1370
498
367
1030
934
Minimum
incorporation
of [1-'*AG] acetate 0.0004% 0.0010%
Table III, 9* Spécifié activities (sp,act,) of
progesterone from successive paper
chromatograms,
Ohromatogram
1
2
5
4
5
Sp,act♦(opm/mg,.) of 
progesterone
Experiment Ila Experiment Ilb
2610
2410
1360
1229
1251
7280
1110
229
437
312
Minimum 
inc orporation
of [l-'*^ oJ acetate 0,0011% 0,0003%
Table III# 10, fSpeçlfic activities (sp»aot*) of
testosterone from successive paper 
chromatograms * The specific activities 
have been calculated as opm, per mg. 
testosterone.
Sp,act «(opm/mg,) of 
testosterone
Chromatogram Experiment Ila Experiment lib
3160 895
2 3034 643
1378
1516
Minimum
incorporation
of [i-'*^ 0] acetate 0.0020% 0.0010%
Table III, 11. Speoifio activities (sp.act*) of
17œ-hydrox;j?progesterQne from succès*
slve paper chromatograms#
Bp#act,(opm/mgi) of 
17a*«h^ droxyprogest erone
Chromatogram Experiment Ila Experiment lib
2750 879
2640 1028
Minimum
incorporation
of [l-^ O^] acetate 0,0021% 0,0008%
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4. M s  eus s Ion
The criterion of radio Chemical purity of the 
steroids studied was constancy of specific activity of 
the crystalline compounds through two or more crystal­
lisations or constancy of specific activity of the 
neutral steroids through two or more paper chromato­
grams# On this basis it has been shown that oestrone 
(XIX) has been synthesised from sodium [l-^ o^j acetate 
in Experiments I and lib* The evidence in Experiment 
Ila is not conclusive. In Experiments Ila and lib^  
radioactive oestradiol acetate was found# Erom a 
comparison of the specific activities of the acetate 
with those of the hydrolysed product * it is apparent 
that the acetate moieties are not themselves radio­
active* Thus it is likely that the acétylation has 
occurred during the extraction procedure# The only 
probable stage where this might happen is the micro- 
Girard separation of *oestrone’ and *oestradiol* 
fractions# If trace amounts of acetic anhydride were 
present in the glacial acetic acid used, acétylation 
may have taken place# Pad!oactive oestrlol (XXI) was 
not found in any of the three experiments.
Testosterone (XVI) and 17a-hydroxyprogester- 
one (VI) in Experiments Ila and lib, androstenedione
(XIV) in Experiment lib and progesterone (II) in 
Experiment Ila were adjudged to be radioactive by the 
criterion defined above. Study of these compounds
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was limited by the recovery both of material and of 
radioactivity from each successive paper chromatogram..
It is possible that on the paper chromatograms other 
compounds, possibly radioactive, may have the same 
mobilities as androstenedione (XIV) and progesterone 
(II) respectively, in the ligroin-propylene glycol 
solvent system used* The same criticism may be held 
against the evidence for the radiochemical purity of 
the testosterone (XVI), and 17a-hydroxyprogesterone 
(VI)* It is felt however that with the acétylation 
necessary for the separation of these two compounds 
from one another, a more rigorous purification of 
testosterone (XVI), and IVcc-hydroxyprogesterone (VI) 
has been achieved* Further work on these four neutral 
steroids was not feasible because of the low levels 
of radioactivity in the eluates from the final paper 
chromatograms.
Some idea of the effect of the presence of 
human menopausal gonadotrophin in the incubation 
medium may be reached by a comparison of the minimum 
incorporation of [i--’^ g] acetate into each steroid in 
Experiments Ila (with gonadotrophin) and lib (without 
gonadotrophin). On the other hand no comparison 
should be made of the levels of activities of oestrone
(XIX) and oestradiol-170 (XX) because of technical 
differences* Whereas in Experiment Ila the Phenols- 
Acids fraction (7000 opm) was separated into an
55 ■
'oestriol* fraction (970 opm) and an *oestrone- 
oestradiol* fraction (7770 opm), giving a 125% recovery 
of radioactivity, in Experiment Ilb on the other Inmd 
this same separation was carried out with a recovery 
of only 36%, the Phenols-Acids (8900 opm) giving rise 
to an *oestriol* fraction (1550 opm) and an *oestrone- 
oestradiol* fraction (1850 opm)# It is obvious that 
this difference in efficiency of recovery precludes the 
possibility of comparing the oestrones and oestradiols 
from Experiments Ilaand Ilb,
The effect of human menopausal gonadotrophin 
on the incorporation of ’^ G-aoetate into the four 
neutral steroids is shown in Table III.12, Human 
menopausal gonadotrophin has increased the incorpora­
tion into progesterone (II), testosterone (XVI) and 
17u-hydroxyprogesterone (VI), This is in contrast to 
the incorporation into androstenedione (XIV) which is 
greater in the experiment without gonadotrophin*
These effects may have been caused however, not by the 
presence or absence of human menopausal gonadotrophin 
but rather by a metabolic difference in the tissue.
The tissue in Experiment Ila came from the left ovary 
whereas tissue from the right ovary was used in 
Experiment lib*. There is a possibility of the presence 
of a quantitative difference in the enzyme activity 
between the two ovaries, particularly if some error in 
metabolism is present.
Table III, 12. Effect of human menopausal gonado­
trophin (I#G) on the incorporation 
Of acetate into androstenedione,
progesterone, testosterone and 
17a-hydroxyprogesterone
Minimum Incorporât ion 
of . [l-^  *o] acetate
Steroid Experiment Ila Experiment Ilb
(with BMG) (without HMG)
Androstenedione 0.0004%
Progesterone 0.0011%
Testosterone 0*0020%
0.0010%
0.0003%
0.0010%
17a-Hydroxy-
progesterone 0.0021% 0.0008%
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Since the preliminary report of this present 
study appeared (O'Donnell and McGaig, 1959) several 
authors have published the results of in vitro incuba­
tions of ovaries including those from women with the 
Stein-Leventhal syndrome. Wotiz and Lemon (1958) 
reported that slices of several human ovaries inolud- 
ing Stein-Levanthal ovaries converted [l-^ o^] acetate 
to ^^0-oestrone (XIX) and ^♦0-oestradiol-17P (XX), 
However, it is not clear from this abstract whether 
the Stein-Levanthal ovaries were included in the group 
of ovaries capable of synthesising oestrone (XIX) and 
oestradiol (XX). Slices of Stein—Levanthal ovaries 
have been shown by Goldsieher and Axelrod (I960) to 
convert ^*0-progesterone (II) to oestrone (XIX), 
oestradiol-l7p (XX), 17u-hydroxyprogesterone (VI), 
testosterone (XVI) and androstenedione (XIV)• These 
results support those presented in this thesis. The 
finding of testosterone (XVI) in both these studies is 
in contrast to the data of Sweat et al.% (I960), in 
which no evidence could be found for the synthesis of 
testosterone (XVI) in human ovarian tissue. Sweat 
and his co-workers, however, do report the synthesis 
of oestrone (XIX), oestradiol-17P (XX), androstenedione 
(XIV) and ITa-hydroxyprogesterona (VI) from i^ G-pro- 
gesterone (II). In addition Sweat et al. (I960) 
present evidence for the synthesis of ^*G-progesterone 
from [i-'‘^ g] acetate in bovine ovarian tissue.
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The results of Lanthier and Bandor (I960) 
may point to one possible explanation of the excessive 
androgen production causing the hirsutism associated 
with the Stein-Levanthal syndrome. After incubation 
of slices of normal ovaries Lanthier and Bandor detected 
trace amounts of androstenedione (XIV) in the medium, 
especially when the tissue was incubated in the presence 
of a precursor (pregnenolone (XI) or ITu-hydroxypro- 
gesterone (VI)) and human chorionic gonadotrophin.
Slices of Btein-Leventhal ovaries incubated under the 
same conditions gave rise to increased amounts of 
androstenedione (XIV) in the medium as compared with 
the normal ovaries.
However excessive androgen production by the 
ovary does not appear to explain all the features of 
this syndrome. The elevated urinary 17-ketosteroids 
found by several workers (Perloff et al., 1957;
Gallagher et al,, 1958; Lanthier, I960) and the 
suppression of this level by corticosteroids remind 
us once more of the possibility of a precursor 
elaborated from the adrenal oortexi
38.
Section IV ? Incubation of feminising adrenal tumour 
with sodium [l-^ *Q acetate and [4-1*0
progesterone.
1.# Introduction
The literature concerning the rare condition 
of adrenal carcinoma with gynecomastia and féminisation 
has been reviewed by Wallach et al,, (1957)* Subse­
quent to the thirty-four cases reviewed by there 
authors, several other feminising adrenal tumours 
have been reported (Wolf et al,, 1958; Snalth, 1958; 
Keller et al.% 1958; Tourneur et al.% I960; Ferrier 
et al,, I960), Because of the rarity and the individ­
ual clinical manifestations of this condition, the 
symptoms which cause the patient to present himself 
are very varied, although gynecomastia is usually 
present, often preceding the appearance of other 
symptoms by many months. However, in almost every 
case in which the urinary oestrogens have been deter­
mined, either by a chemical method or by a bioassay, 
they have been found to be higher than normal. Removal 
of the tumour results in a dramatic fall in the level 
of urinary oestrogens, Pregnane-3otî20a-diol (pre- 
gnanediol, XXVII) has been found in elevated amounts 
in the urine of some patients before operation. In 
some, but not all cases large amounts of urinary
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17-ketosteroids have been found. In instances where 
these 17-ketosteroids have been fractionated large 
amounts of dehydroepiandrosterone (XIII) and aetiocho- 
lanolone (XXVI) have been found. Removal of the 
tumour also diminished the high levels of 17-ketosteroids 
The foregoing laboratory findings suggest 
that these adrenal tumours synthesise steroids in large 
amounts, a large proportion of these being aromatised 
in ring A to give oestrogens. However it is possible 
that these oestrogens are in fact formed from the 
adrenal steroids in tissues other than, the adrenal 
cortex e.g. liver tissue. Much interest was aroused 
when Salhanick and Berliner (1957) reported the isola­
tion of steroids from a feminising adrenal tumour.
They detected eight steroids from the 920 g. tumour, 
two of which were identified as progesterone (II, 850 
pg.) and 3-hydroxyoestra-lî3«5(lÛ)s6:8-pentaen-17-one 
(equilenin, XXVIII). This was the first report of 
the isolation of eguilenin from a human source*
Prior to the initiation of the studies to be 
presented in this thesis, only one series of in vitro 
incubations of slices of feminising adrenal carcinoma 
had been reported (Unpublished note cited in Baggett 
et al.. 1956). Subsequently the results of these 
incubations were published in full by Baggett et al., 
(1959). When Baggett and his co-workers incubated
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slices of the tumour with acetate (50 p,c), no
measurable radioactivity was detected in the oestrogens, 
nor could any labelled neutral steroids be isolated* 
Incubation of slices with [3^14o] testosterone (XVI) 
resulted in radioactive oestrone (XIX), oestradiol-17|3
(XX) and in a compound very similar to oestriol (XXI) 
but which could be separated from oestriol by either 
méthylation or a 250-transfer counter current distri­
bution. These observations show that this carcinoma 
was capable of synthesising oestrogens.
The possibility that the adrenal gland is 
capable of synthesising oestrogens has been supported 
by the isolation of oestrogens in extracts of adrenal 
tissue* Beall (1959) isolated oestrone (XIX) from 
bovine adrenal extracts. The isolation of equilenin 
(XXVIII) from a feminising adrenal tumour (Salhanick 
and Berliner, 1957) has been described above and Keller 
(1958) reports tentative evidence for the presence of 
oestradiol-17P (XX) and oestrone (XIX) in extracts 
from an adrenal carcinoma* Oestrogen biosynthesis in 
the adrenal is also suggested by the finding of urinary 
oestrogens persisting after bilateral ovariectomy. 
However these oestrogens do disappear on subsequent 
bilateral adrenalectomy.
Synthesis of oestrogens in adrenal tissue was 
demonstrated by Meyer (1955) when he isolated oestrone 
(XIX) after incubation of bovine adrenals with
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19-*hydroxyandrostenedioiie (XXIV) • Thus it appears 
that the adrenal, like the ovary and placenta, is 
capable of synthesising oestrogens.
The synthesis of corticosteroids, progesterone 
and androgens in adrenal tissue has been discussed in 
Section I.
In the following studies, tissue was obtained 
from a 39’*year-old man undergoing surgery for the re­
moval of a feminising adrenal tumour (wet wt. 1100 g.). 
Prior to the operation, the urinary levels of oestro­
gens, pregnanediol (XXVII) and 17-ketosteroids were 
elevated, but diminished markedly on removal of the 
tumour. Before operation, the intravenous infusion of 
AOTH caused only a slight elevation in the already 
high level of plasma 17-hydroxyoortioosteroids. Follow­
ing extirpation of the tumour, the remaining adrenal 
showed a response to exogenous IGTH although to a lesser 
extent than in normal individuals. À comprehensive 
study was made on an extract of a portion (501 g.) 
of tumour but no evidence was obtained for the presence 
of any steroids (0*Donnell et al., I960).
Slices and homogenate preparations of the 
tumour were incubated with l-'*‘*cj acetate and |4-‘'^ g] 
progesterone. In the following report, the investiga­
tions on the capacity of the tissue to synthesise 
steroids are presented.
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2a* Incubation conditions*
Tumour slices (5-4 g.) were incubated in 
25 ml* of Krebs-Ringer phosphate buffer, pH 7.4, con­
taining glucose (0.01 M), fumarate (0.01 M) and 
nicotinamide (0,04 M) together with the substrates and 
cofactors listed in Table IV.1. Incubation was carried 
out for 3 hours with shaking, in an atmosphere of 
oxygen at 37"^ 0.
30*6 g. of tumour tissue was homogenised in 
Krebs-Ringer phosphate buffer (pH 7.4). The total 
volume of the homogenate was 150 ml. (340 mg. wet 
weight tissue per ml.; 53.9 mg. dry weight tissue per 
ml.).
25 ml. portions of the homogenate were in­
cubated for 3 hours with shaking, under an atmosphere 
of oxygen, together with glucose (0.01 M), nicotinamide 
(0.04 M), fumarate (0.01 M), adenosine triphosphate 
(0.005 M) and triphosphopyridine nucleotide (0.0005 M). 
The following substrates were added:
1. sodium „l-‘*^ o] acetate (25 mg. ; 50 jxo)
2. [4-* *0 progesterone (30.8 g^. ; 2 pc) , 
dissolved in propylene glycol (0.2 ml.).
2b. Extraction and Purification Procedure.
In the experiments using tissue slices, the 
slices were homogenised in water (20 ml. approx.) and
Table IV* 1. Incubation of feminising adrenal
tumour slices with various substrates 
and cofactors*
Expt* Wt* slices Substrate Oofactor
Ho. (g.)
1 3.10 sodium 3j acetate -
25 mg.; 50 pc
2 3.59 sodium 3] acetate AOTH
25 mg. 5 50 pc 30 i.u.
3 3*69 sodium j acetate Human menopausal
25 mg.; 50 pc gonadotrophin
(HMG)
25 mg. ; 25 units
4 3.56 [4-.’t4o] progesterone*
30.8 pg*; 2 pc
The progesterone was dissolved in propylene
glycol (0*2 ml*).
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this homogenate added to the incubation medium. The 
horaogenates from all experiments were extracted with 
ethyl acetate (3 x 50 ml.) and chloroform (3 x 50 ml.)# 
The residue was partitioned between heptane (100 ml.) 
and 90% methanol (100 ml*). The phases were separated 
and each was shaken with 50 ml. of fresh opposite phase# 
These two 50 ml. phases were shaken together* The 
combined heptane phases and the combined 90% methanol 
phases were evaporated to dryness in vacuo*
The methanol fraction of the ♦^G-acetate 
(homogenate) experiment was resolved by paper chromato­
graphy using the toluene-propylene glycol and ligroin­
propylene glycol solvent systems. Ho steroids could 
be detected. Thus it was found necessary to add 
imlabelled steroids as carriers.
Addition of carrier steroids*
The following carriers (1 mg* approx.) were 
added to the ^^ C-progesteroae (homogenate), ^^ G-acetate 
(control),  ^"^ C-acetate (IMG) and ’
(slice) experiments: cortisol (VIII), corticosterone 
(IV), ll“deoxyoortisol (VII), 17a-hydroxyprogesterone 
(VI), deoxycorticosterone (III), dehydroepiandrosterone 
(XIII), androstenedione (XIV), oestradiol (XX), oestrone 
(XIX) and oestriol (XXI). These carriers were added 
to the crude ethyl aoetate-chloroform extract. The
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same carriers with the exception of oestriol were added 
to the methanol fraction of the "^^ G-acetate (AOTH) 
incubation.
The steroids were partially resolved by 
column chromatography on silica gel ("Davison" 923, 
100/200 mesh)♦
To a column, 1 cm. diameter, of silica gel 
(8-10 g.) in benzene, the residue from the 90% methanol 
fraction was added dissolved in benzene (25 ml.)* The 
following elutions were made: benzene (10-25 ml,;
bright yellow); ethyl acetate in benzene (v/v):1%
(50-70 ml.), 2% (70-85 ml*), 4% (70-100 ml.), 10% 
(100-120 ml*), 20% (80-100 ml*) and 40% (100 ml.); 
ethyl acetate (100-120 ml.); ethanol (75-*100 ml*; straw 
coloured) and chloroform (100 ml.). Except where noted 
otherwise, the eluates obtained were colourless* From 
the absorption spectra in methanol of the residues 
from these eluates, it was found that the steroids 
appeared in the eluates 10% (v/v) ethyl acetate in 
benzene to 100% ethyl acetate. The ethanol, eluate 
(straw coloured) was shown to consist almost entirely 
of nicotinamide*
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Paper Chromatography.
The steroids of the 10%, 20% and 40% (v/v) 
ethyl acetate in 'benzene and the 100% ethyl acetate 
eluates were resolved by paper chromatography using 
the toluene-propylene glycol and ligroin-propylene 
glycol solvent systems.
They were first run in the solvent system 
toluene-propylene glycol for 48 hours, thus separating 
oestriol (XXI), cortisol (VIII), oestradiol (XX), 
11-deoxyoortisol (VII) and corticosterone (IV). By 
paper chromatography of the overflow in ligroin­
propyl one glycol for 48 hours, oestrone (XIX), 17a- 
hydroxyprogesterone (VI) and deoxycorticosterone (III) 
were separated* The overflow from this was in turn 
chromatographed in ligroin-propylene glycol until the 
solvent front reached the end of the papergram (about 
8 hours)* On this chromatogram, androstenedione and 
progesterone were separated. A diagram of the separa­
tion of the steroids by paper chromatographic systems 
is shown in Fig, IV*1*
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3• Results
(i) Incubation of slices with |l**^ o^j acetate in the 
presence of AOTH.
The detected steroids were further purified 
by repeated paper chromatography. When the specific 
activities of androstenedione (XIV), 17u-hydroxypro- 
gesterone (VI) and progesterone (II) were constant, 
each was dissolved in pyridine and acetic arihydride 
was added. Subsequent chromatograms separated any 
easily acetylable impurity from the steroid being 
studied.
a) Cortisol (VIII).
After three successive paper chromatograms 
in the toluene-propylene glycol solvent system, the 
specific activity of the cortisol was constant at 1800 
opm per mg. The specific activities of the material 
isolated from each chromatogram are shown in Table 
IV.2. The spectrum of a sulphuric acid chromogen of 
the final material (37 pg./3 ml., Eg80^ ) was identical 
with that of authentic cortisol (Section II);
Max. mp (O.D.) : 234 (0.540) [l]; 279 (0.500)% 392 (0.240);
466 (0.305).
Min. mp(O.D.): 251 (0.369); 348 (0,144); 410 (0.201).
Table IV. 2 Specific activities of cortisol from 
successive paper chromatograms. 
Incubation of tumour slices with 
[i-’^ g] acetate and AGTH.
Chromatogram Sp.act.(opm per mg.)
1
2
3
2453
2060
1800
Carrier added 1058 J i g .
Minimum incorporation of 
[^1-^ o^J acetate 0.0029%
47,
b) Androstenedione (XIV).
After four paper chromatograms in the solvent 
system ligroin-propylene glycol the specific activity 
of androstendion© was constant at 931 opm per mg. 
Acétylation and subsequent chromatography freed the 
material of a radioactive impurity. After a further 
three paper chromatograms in the same system the 
specific activity of the androstenedione was constant 
at 203 opm per mg. The specific activities of the 
material after each chromatogram are shown in Table 
IV.3, The spectrum of a sulphuric acid chromogen of 
the material (24.5 }ig,/3 ml. HgSO^ ) before acétylation 
was identical with that of authentic androstenedione 
(Section II):
Max. mju(0.D.); 295 (0.628)
Min. mp (O.D.) : 236 (0,129)
c) IVa-Hydroxyprogesterone (VI).
Four paper chromatograms, the first two in 
the ligroin-propylene glycol, the second two in the 
toluene-propylene glycol solvent system yielded material 
of specific activity 8385 cpm per mg. Acétylation and 
another chromatogram in the solvent system toluene- 
propylene glycol caused the specific activity of the 
17a-hydroxyprogesterone to drop to I47I cpm per mg.
The specific activities of the material obtained from
Table IV. 3» Specific activities of androstenedione
from successive paper chromatograms. 
Incubation of tumour slices with 
[l-^ o^] acetate and AOTH.
Ohromatogram
1
2
3
4
Acétylation + 5
6
7
Carrier added
Minimum incorporation of 
[l-i^ o] acetate
Sp.act.(cpm per mg.)
2127
1218
1014
931
335
175
203
1053 ps 
0.0003%
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each chromatogram are shown in Table IV, 4. Insufficient 
material remained for further purification. The spec­
trum of a sulphuric add chromogen of material (24.8 
jxg»/3 ml. EgSO^ ) before acétylation was identical with 
that of authentic 17a-hydroxyprogesterone (Section II): 
Max. mji (O.D.) : 244 (0.232) [l]; 288 (0.509); 428 (0,263). 
Min. mp (O.D,); 253 (0,223); 345 (0,069).
d) Px*ogesterone (II)
Progesterone, after four chromatograms in the 
1igr0in-propy1ene glycol solvent system had a constant 
specific activity of 1727 cpm per mg. Acétylation 
and a further three chromatograms in the same system 
yielded progesterone of constant specific activity 694 
cpm per mg. The specific activities of the material 
obtained from each ohromatogram are shown in Table 
IV,5. The spectrum of a sulphuric acid chromogen of 
material (52 jug./3 ml. H^ SO^ ) before acétylation was 
identical with that of authentic progesterone 
(Section II);
Max,mp (O.D.)I 233 (0.440); 291 (1,110).
Min. mp (O.D,): 224 (0.432); 236 (0,432).
e) Oestrone (XII)
One paper chromatogram in the ligroin- 
propylene glycol and two in the toluene-propylene
Table IV* 4», Specific activities of 17a-hydroxy*
progesterone from successive paper
chromâto grams $
Incubation of tumour slices with 
acetate and AGTH*
Chromatogram Sp •act. (cpm per mg*.)
1 4482
2 17090
3 7550
4 8385
Acétylation + 5 1471
Carrier added 1008 pg
Table IV. 5. Specific activities of progesterone from 
successive paper chromatograms 
Incubation of tumour slices with
[1-1 40_acetate and AOTH.
Chromatogram Sp.act.(cpm per mg.)
1
2
3
4
Acétylation + 5
6
7
6430
3286
1758
1727
1275
697
694
Carrier added
Minimum incorporation of 
[l-i4c] acetate
1022 Jig) 
0.0011%
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glycol solvent systems yielded oestrone of specific 
activity 114 cpm per mg. The specific activity of the 
oestrone diminished with each chromatogram step. The 
specific activities of the material obtained from each 
chromatogram are shown in Table IV. 6. The spectrum of 
a sulphuric acid chromogen of the final material (47.2 
pg./3 ml. Hg80^ ) was identical with that of authentic 
oestrone (Section II):
Max. mjüi (O.D.): 227 (0.497)[l]; 300 (0.671); 446 (O.39O). 
Min. m j L i  (O.D.): 256 (0.157); 575 (0.059).
f) Oestradiol-17B (XX).
Two paper chromatograms in the toluene- 
propylene glycol solvent system yielded material of 
specific activity 46.5 cpm per mg. There was no con­
stancy in the specific activities. The results from 
both chromatograms are shown in Table IV. 7. The 
spectrum of a sulphuric acid chromogen of the final 
material (44.7 pg./5 ml. H^ SO^ ) was identical with 
that of authentic oestradiol (Section II):
Max. mji (O.D.): 275 (0.269)[l]; 282 (0.274); 302
(0.300); 366 (0.77% 422 (0.669).'
Min. mjx (O.D.): 258 (0.224); 287 (0.270); 319 (0.254);
389 (0.407).
Table TV. 6 Specific activities of oestrone from 
successive paper chromatograms. 
Incubation of tumour slices with 
[i-14q] acetate and AOTH.
Chromatogram Sp.act.(cpm per mg.)
1 2074
2 420
3 114
Carrier added 970 jig.
Table TV. 7. Specific activities of oeatradiol-
17P from successive paper chromatograms. 
IrLOubation of tumour slices with 
[l-^ o^] acetate and AOTH.
Chromatogram Sp.act.(cpm per mg.)
1 122 
2 46.5
Carrier added 1004
r 1(ii) Incubation of Slices with acetate.
a) Gortisol (VIII)
Of the 997 pg* carrier cortisol originally 
added $ 558 pg. was recovered of specific activity 5116 
cpm per mg. Additional carrier cortisol was purified 
by column chromatography on silica gel, followed by 
repeated crystallisations (final m.p. 189-198.5°)*
On a paper chromatogram, it behaved as a homogenous 
substance. 15*19 mg. of this material was added to the 
radioactive material to give a total weight of 16*12 mg. 
of specific activity 125 cpm per mg. Two crystallisa­
tions were performed, the first from aqueous methanol, 
the second from ether-methanol. The final crop of 
crystals (8.51 mg.) had a specific activity of less 
than 5 cpm per mg. The results are shown in Table IV.8. 
The spectrum of a solution of the final material in 
methanol showed a maximum at 242 mjx (Ç - 16,550).
The spectrum of a sulphuric acid chromogen of the final 
material (55*24.pg*/5 ml. HgGO^ ) was identical with 
that of authentic cortisol (Section II):
Max. mp (O.P.); 229 (0.570) [l]; 270 (0.502);
594 (0.226); 471 (0.530).
Min. mp (O.P.): 281 (0.568); 557 (0.117); 408 (0.201).
Table IV. 8. Results of crystallisation of cortisol:
weights, m.p.*s and specific activities 
of crystals; weights and specific 
activities of mother liquors*
Incubation of tumour slices with 
4c] acetate*
C R Y S T A L S  MOTHER LIQUORS
Oryst. Wt. M.p. Sp .act. V/t. Sp.act*
(mg.) (cpm per mg.)(mg*)(cpm per mg.)
1 11.69 190-197° 52*9 5.69 408
2 8.51 186-194° 5 2.60 94.5
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b ) Andros ten edi one (XIV) *
After elution from the initial chromatogram 
in the solvent system ligroin-propylene glycol, the 
androstenedione was dissolved in pyridine and acetic 
anhydride added. The androstenedione was further 
purified by two paper chromatograms in the ligroin­
propylene glycol solvent system and had a final specific 
activity of approximately 20 cpm per mg. The specific 
activity of the androstenedione diminished at each 
stage of the purification procedure. The specific 
activities of the material obtained from each of these 
chromatograms are shOüvn in Table IV. The spectrum 
of a sulphuric acid ohromogen of the final material 
(12 pg./3 ml. ÏÏ2SO4) was identical with that of 
authentic androstenedione (Section II):
Max, mp (O.P.); 292 (0.269).
Min. mp (O.P.); 256 (0.061).
c ) ITtt-Hydroxyprogesterone (VI)
The specific activity of the 17a-hydroxy- 
progesterone recovered from the initial chromatogram in 
the ligroin-propylene glycol solvent system was 985 cpm 
per mg. After subjection to acétylation conditions and 
a further chromatogram in the ligroin-propylene glycol 
solvent system, the specific activity of the 17cc- 
hydroxyprogesterone decreased to 287 cpm per mg.
Table IV. 9# Specific activities of androstenedione
from successive paper chromatograms* 
Incubation of tumour slices with 
[l-^ '^ o] acetate.
Chromatogram Sp.act,(cpm per mg.)
1215
Acétylation +2 66.5
20 (approx.)
Carrier added 987 pg
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Unfortunately the amount of material remaining did 
not permit further purification.
d) Progesterone (II).
After the initial paper chromatogram in the 
ligroin-propylene glycol solvent system, the progester­
one was subjected to acétylation conditions and purified 
by two further chromatograms in ligroin-propylene glycol. 
The progesterone then exhibited a constant specific 
activity of 112 cpm per mg. The specific activities 
of the material obtained from these chromatograms are 
presented in Table IV.10. The spectrum of a sulphuric 
acid chromogen of the final material (25,6 jig./5 ml.
HaSO4) was identical with that of authentic progesterone 
(Section II):
Max. mp. (O.P.) I 291 (O.4IO),
Min. mp (O.P.); 224 (0.159).
e) Oestrone (XIX).
Oestrone was chromatographed twice in the 
ligroin-propylene glycol solvent system, then acetylated 
and purified by a paper chromatogram in ligroin-propyl­
ene glycol, yielding material of final specific activity 
154 cpm per mg. free oestrone. At each stage, the
specific activity of the oestrone diminished. The
specific activities of the material obtained from
Table IV, 10, Specific activities of progesterone
from successive paper chromatograms. 
Incubation of tumour slices with 
[l-^ -^ o] acetate.
Chromatogram Sp.act.(cpm per mg.)
1 1144
Acétylation + 2 105
3 112
Carrier added 1056
Minimum incorporation of 0.00018%
[l-‘*^ (^  acetate
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these chromatograms are shown in Table IV. 11, The 
speotrum of a sulphuric acid chromogen of the final 
material (51.4 pg. acetate/5 ml. HgSO^ ) was identical 
with that of authentic oestrone acetate (Section II):
Max. mp (O.D.): 228 (0*260) [l]; 501 (0.542); 448 (0.231). 
Min. mju (O.D.): 250 (0*094); 57B (0*041).
f) Qestradiol-173 (XZ).
Two paper chromatograms of oestradiol were 
run in the toluene-propylene glycol solvent system 
yielding oestradiol of final specific activity 92.2 
cpm per mg, Wo constancy of specific activity was 
achieved. The specific activities of the material 
obtained from these chromatograms are shown in Table 
IV,12, The spectrum of a sulphuric acid ohromogen of 
the final material (25.4 pg./5 ml. HgSO^ ) was identical 
with that of authentic oestradiol (Section II):
Max. mp. (O.D.): 234 (0.247) [l]* 269 (0.167);
302 (0.161); 366 (0.410); 426 (0.518); 
446 (0.330) [ij.
Min. mp (O.D.)s 252 (0.155); 285 (0.150); 320 (0.131);
390 (0.275).
S )  Oestriol (XXI).
After recovery from the initial chromato­
gram in the toluene-propylene glycol solvent system,
Table IV. 11. Specific activities of oestrone from 
successive paper chromatograms. 
Incubation of tumour slices with 
[l-’*o] acetate•
Chromatogram Sp.act.(cpm per mg.)
1289
1416
Acétylation + 5 154 (calculated 
as free oestrone)
Carrier added 1111 pg.
Table TV. 12. Specific activities of oestradiol-17P
from successive paper chromatograms* 
Incubation of tumour slices with 
[i-'*+g] acetate.
Giiromatogram Sp.act.(cpm per mg.)
1 265
2 92.2
Carrier added 1084 fig.
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oestriol was acetylated and purified by a paper 
chromatogram in the ligroin-propylene glycol system.
The specific activity of the final material was 103 
cpm per mg. free oestriol. The specific activity of 
the oestriol was not constant. The specific activities 
of the material obtained from these chromatograms are 
shown in Table IV.13. The spectrum of a sulphuric 
acid ohromogen of the final material (27*2 jig. acetate/ 
ml. H28O4) was identical with that of authentic 
oestriol acetate (Section II):
Max. mp (O.D.): 231 (0.500) [l]; 305 (0.332);
354 (0.076); 448 (0.107).
Min. mp. (O.D.) : 262 (0.0825); 333 (O.O7O); 387 (O.O5O).
Table IV. 13. Specifio activities of oestriol after
successive paper ohromatograias. 
Incubation of tumour slices with 
[i*.i4q ] acetate-
Ohromatogram
1
Acétylation + 2
Sp.act.(cpm per mg.)
5962
103 (calculated 
as free oestriol)
Carrier added 1199 pg-
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(ill) Incubation of siloes with acetate in
the presence of human menopausal gonadotrophin*
a) Gortisol (VIII).
After recovery from the initial papex’ ohro­
matogram in toluene-propylene glycol, cortisol was 
acetylated and purified by two further chromatograms 
in the same solvent system* Constancy in the specific 
activity was not achieved* The final material had a 
specific activity of 155 cpm per mg* free cortisol.
The specific activities of the material obtained from 
each chromatogram are shown in Table IV*14* The 
spectrum of a sulphuric acid chromogen of the final 
material (10.20 jug* acetate/ml. Eg80^ ) was identical 
with that of authentic cortisol 21-monoacetate 
(Section II):
Max. Biju (O.D.): 234 (0.350); 241 (0.330); 252 (0.231) [l];
285 (0.56.7); 389 (0.208); 428 (0.146).
Min. mp. (O.D.): 230 (0.341); 239 (0.326); 250 (0.221);
360 (0.179).
b) Androstenedione (XIV)*
After recovery from the initial paper chro­
matogram in the ligroin-propylene glycol solvent 
system, androstenedione was dissolved in pyridine and 
acetic anhydride added. Three subsequent chromatograms
Table IV. 14. Specific activities of cortisol from
successive paper chromatograms. 
Incubation of tumour slices with 
[l**'*^o] acetate and MG.
Chromatogram Sp.act.(cpm per mg.)
1 850
Acétylation + 2 1005 (calculated 
as free cortisol)
135 (calculated 
as free cortisol)
Carrier added 997
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in the ligroin-propylene glycol solvent system were 
performed. The specific activity of the androstenedione 
fell at each stage. The specific activity of the 
final material was 19#7 cpm per mg. The specific 
activities of the material obtained from each chromato­
gram are shown in Table IV ^15, The spectrum of a 
sulphuric acid ohromogen of the final matez'ial (23*4 
pS#/3 ml. HgSO^ ) was identical with that of authentic 
androstenedione (Section II):
Max. mp (O.D.); 293 (0.472).
Min. mp (OJO.)t 235 (0.095)*
c) 17g-Hydroxypr0gesterone (VI).
After recovery from the initial paper chro­
mât o grain, 17Œ-hy droxypro geste rone was subjected to 
acétylation conditions. Two subsequent paper chromato­
grams were performed in the ligroin-propylene glycol 
solvent system. The specific activity of the final 
material was constant at 427 cpm per mg. The specific 
activities of the material obtained from each chromato­
gram are sho\m in Table IV.16. The spectrum of a 
sulphuric acid ohromogen of the final material (12 
pg./3 ml. H2SO4) was identical with that of authentic 
material (Section II)1
Max. mp (O.P.): 287 (0.260); 430 (0.108).
Min. mp (O.B.)s 241 (0.092); 347 (0.043).
Table rv. 15* Specific activities of androstenedione
from successive paper chromatograms. 
Incubation of slices with [l-''+o] 
acetate and MG.
Chromatogram Sp.act,(cpm per mg.)
1 1859
Acétylation + 2 96.5
3 39*5
4 19.7
Carrier added 987 pg.
Table 17# 16# Specific activities of 17a-bydroxy-
progesterone from successive paper 
chromatograms #
Incubation of slices with [l-’^ o] 
acetate and HMG#
Ohromatogram Sp.act*(cpm per mg*)
1 1265
Acétylation +2 426
3 427
Gaxrier added 884 pg#
Minimum incorporation of 0.0057%
[l^ i4o] acetate
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d) ProResterone (II).
After recovery from the initial paper ohro­
matogram, progesterone was subjected to acétylation 
conditions and subsequently chromatographed three 
times in the solvent system ligroin-propylene glycol.
The specific activity of the final material was constant 
at 177 cpm per mg* The specific activities are shown 
in Table 17.17. The spectrum of a sulphuric acid 
ohromogen of the final material (24.8 pg./3 ml.) y/as 
identical v/ith that of authentic progesterone.
(Section II) ;
Max. mp (O.D.): 292 (0.351).
Min * m p (0.D.): Hone.
After two paper chromatograms, first in 
ligroin-propylene glycol and then in toluene-propylene 
glycol, the oestrone was acetylated. The reaction 
product was chromatographed twice in the solvent 
system ligroin-propylene glycol. The specific activity 
of the final material was 548 cpm per mg. free oestrone. 
Constancy in the specific activity was not achieved.
The specific activities of the material obtained from 
each ohromatogram are shown in Table 17.18. The 
spectrum of a sulphpric acid ohromogen of the final 
material (30*2 pg. acetate/3 ml. HgBO^ ) was identical
Table IV. 17, Specific activities of progesterone
from successive paper chromatograms. 
Incubation of slices with [l-^ o^] 
acetate and MG,
Ohromatogram Sp.act,(cpm per mg.)
1 2195
Acétylation + 2 277
3 164
4 177
Carrier added 1056 pg.
Minimum incorporation of 0.00028%
[l^ i4(j acetate
Table IV. 18. Specific activities of oestrone from 
successive paper chromatograms. 
Incubation of slices with [l-^ o^] 
acetate and HMG*
Ohromatogram Sp.act.(cpm per mg.)
2993
3266
Acétylation + 3 661 ( calculated 
as free oestrone)
548 (calculated 
as free oestrone)
Carrier added 1111 jug,
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with that of authentic oestrone acetate (Section II): 
Max. mji (O.D.)i 250 (0.192) [l]} 300 (0.276);
450 (0.186).
Min. mp (O.D.)i 250 (0.074); 365 (0.060).,
f) 0estradlol--17B (XX).
After two paper chromatograms in the solvent 
system toluene-propylene glycol, the specific activity 
of the oestradiol was 55,5 cpm per mg. Constancy in 
the specific activity was not achieved. The specific 
activities of the material obtained from each chromato­
gram are shown in Table IV.19*. The spectrum of a 
sulphuric acid chromogen of the final material (32.8 
pg./3 ml. HgSO )^ was identical with that of authentic 
oestradiol (Section II):
Max. mp (O.D.): 256 (0.403); 301 (0.189); 366 (0.441);
426 (0.562); 446 (0.345) [l] .
Min. mp (O.D.)i 237 (0.290); 284 (0.176); 320 (O.I5I);
390 (0.291)..
g) Oestriol (XZI).
After recovery from the initial paper ohro­
matogram, oestriol v/as acetylated and subsequently 
chromatographed three times.. The specific activity 
of the final material was 202 cpm per mg. free 
oestriol. The specific activity diminished at each
Table IV. 19. Specific activities of oestradiol from
successive paper chromatograms. 
Incubation of slices with [l-’*oJ 
acetate and fflG*
Ohromatogram Sp.act.(cpm per mg.)
1 93.4
2 55-5
Carrier added 1084 pg.
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stage of the purification.- The specific activities 
of the material obtained from each chromatogram are 
shown in Table IV.20. The spectrum of a sulphuric 
acid chromogen of the final material (20.0 pg. acetate/ 
ml. HgSO^ ) was identical with that of authentic 
oestriol triacetate (Section II) i 
Max. mp (O.D.); 231 (0.240) [l]; 304 (0.169);
354 (0.0925); 449 (0.070).
Min. mp (O.D.); 266 (0.,095); 340 (0.090); 420 (0.060).
Table IV. 20. Specific activities of oestriol from 
successive paper chromâtograms. 
Incubation of slices with [l-^ o^] 
acetate and HMG*
Chromatogram
1
Acétylation + 2
Sp.act.(cpm per mg.)
786
470 (calculated 
as free oestriol)
266 (c alculat ed 
as free oestriol)
202 (calculated 
as free oestriol)
Carrier added 1199 pg,
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(iv) Incubation of slices with [4^ 1 progesterone#
In this experiment, additional carrier 
material was added to each steroid, and the steroid 
purified by repeated recrystallisation# In the cases 
where constant specific activity was achieved, a 
derivative of the steroid was prepared and crystallised*
a) Cortisol (VIII).
Of the 997 pg. cortisol carrier originally 
added, 661.5 pg. of specific activity 148,000 cpm per 
mg. was recovered. Additional carrier cortisol (29.41 
mg., m.p. 189-198.5®, purified as described in Section 
IV, p. 50 ) was added to the radioactive material
to give a total weight of 30.91 mg., specific activity 
3292 cpm per mg* Four crystallisations were performed 
and the results are shown in Table IV.21. The specific 
activity of the final crop of crystals vms 1174 cpm 
per mg. The cortisol was acetylated and the product 
crystallised twice. Under the conditions used, only 
the hydroxyl group at C-21 of cortisol is acetylated.
The specific activities of the crystals and the mother 
liquors are shown in Table IV.21. The specific 
activity of the final material was 1162 cpm calculated 
per mg. free cortisol. The m.p. of a mixture of the 
final crystals with authentic cortisol 21-monoacetate 
(m.p. 200-212^ ) was 199^ 212°. A solution of the final
Table IV. 21. Specific activities, weights and mp.'s
of cortisol after crystallisation, 
acétylation and subsequent crystallis­
ations.
Incubation of slices with [4-‘*^ o] 
progesterone.
Carrier added 997 pg.
Cortisol recovered 661.5 pg*; 148000 cpm per mg,
Additional carrier added 29*41 mg.
Total material 30.91 mg.; 3292 cpm per mg.
C R Y S T A L S  MOTHER LIQUOR
yst* Solvent Wt.
(mg.)
M.p. Sp.actî Wt.
(mg.)
Sp.act
1 Aqueous
methanol
26.52 182-193* 2170 4.29 10586
2 Ether-
methanol
21.93 184-188.5® 1752 3.85 5327
3 Ligroin-
ethanol
15*97 185-192* 1250 6.00 3052
4 Ligroin-
ethanol
10.61 183.5-197® 1174 5.01 1443
Acétylation
Product
11.92 — 1029
1 Aqueous
methanol
9.25 202-210* 1128 2.01 1305
2 Aqueous 7.31 201-210* 1162 1.52 1276
methanol 
*Gpm per mg. free cortisol
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material in methanol exhibited X 241-242 mp
( ^max = :^ 7,140).
b) Androstenedione (XIV)#
Carrier androstenedione was purified by re­
peated crystallisations to give material of m.p. 169.5- 
171®.
Of the 1026 pg. carrier androstenedione 
originally added, 779 pg. was recovered, of specific 
activity 11,160 cpm per mg. Additional carrier material 
(19*22 mg.) was added to the radioactive material to 
give a total weight of 20.30 mg., specific activity of 
539 cpm per mg. calculated. The material was crys­
tallised tliree times and the specific activity of the 
final material was 353 cpm per mg. The bis-dinitro- 
phenylhydrazone of androstenedione was prepared 
(Section II), purified by silica gel column chromato­
graphy and crystallised. The final specific activity 
of the derivative was 369 cpm per mg. free androstene­
dione. The crystals melted with decomposition at 
about 300*. Authentic androstenedione bis-dinitro- 
phenylhydrazone, and a mixture of the two, also melted 
with decomposition at about 300*. The spectrum of a 
solution of the crystals in chloroform was identical 
with that of authentic material:
Max. mp (E ): 259 (2=30,070); 290 (2=14,185) [l];
378-379 (2=49,270).
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Min. mji (g ): 312-313 (^ =7,801).
The androstenedione his-dinitrophenylbydrazone was 
hydrolysed (Section II) and the androstenedione purified 
by two paper chromatograms in the solvent system ligroin- 
propylene glycol. The specific activity was 403 cpm 
per mg. The spectrum of a sulphuric acid chromogen 
of the final material (23.9 p,g./3 ml. HgSO^ ) was iden­
tical with that of authentic androstenedione (Section 
II):
Max. my. (O.D.): 292 (0.540)
Min. mji (O.D.): 237 (0.102)
The specific activities of the material at every stage 
of the purification are shown in Table IV.22.
o) 17a-Hydroxyprogesterone (VI).
Carrier 17a-hydroxyprogesterone was purified 
by crystallisation from aqueous methanol to give 
material which exhibited a m.p. 203-207®.
Of the 750.7 pg. carrier 17(x-hydroxyprogester- 
one originally added, 552 pg. was recovered, of specific 
activity 12,554 cpm per mg. Additional carrier mate­
rial (25.30 mg.) was added to the radioactive material 
to give a total weight of 26.29 mg. of specific 
activity 240 cpm per mg.
Three crystallisations were performed. The 
specific activity after the third crystallisation was 
14.40 cpm per mg. This material was subjected to the
Table IV. 22. Specific activities, weights and m.p* *s
of androstenedione after crystalli­
sation, formation of bis-dinitrophenyl- 
hydrazone (bis-DHP) and subsequent 
hydrolysis.
incubation of slices with 
progesterone.
Carrier added 1026 jug.
Androstenedione recovered 779 pg. ; 11160 cpm per mg.
Additional carrier added 19*22 mg.
Total material 20.30 mg.; 539 cpm per mg.
G R Ï S T A L S MOTHER LIQUOR
Gryst. Solvent Wt.
(mg.)
M.p. Sp.actÎ Wt. 
(mg.)
Sp.act Î
1 Aqueous
methanol
14.54 165-169.5° 490 5.27 1149
2 Aqueous
methanol
11.66 166.5-170° 374 2,80 593
3 Aqueous
methanol
8.98 167-170° 353 2.56 434
Bis-DNP Product 27.49 - 209
Gryst # Ohloro- 9.20 300°d 369 10.60 223
form
Hydrolysis and 937 pg. - 403
Paper chromato­
graphy (2 X)
Cpm per mg. free androstenedione
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usual acétylation conditions, under which ITa-iiydroxy- 
progesterone is not acetylated, and the resulting mate­
rial after crystallisation had a specific activity of 
15*03 cpm per mg. The specific activities of the crys­
tals and mother liquors are shown in Table IV#23*
d) Progesterone (II).
Of the 966 Jig. carrier progesterone added,
810 J i g *  was recovered of specific activity 15,358 cpm 
per mg* Uo attempt was made to establish the radio­
chemical homogeneity of this progesterone sample.
e) Qestrone
Oarrier oestrone was purified by crystallisa­
tion from aqueous methanol to give material of m.p. 
248-251*.
Of the 1013 Jig. carrier oestrone originally 
added, 437 Jig* was recovered of specific activity 872 
cpm per mg. Additional carrier oestrone (6.72 mg.) 
was added to the radioactive material to give 7.28 mg. 
total weight of specific activity 32.7 cpm per mg.
One crystallisation from aqueous methanol yielded 
5.24 mg* crystals (m.p* 234-242®) of negligable radio­
activity* The mother liquor (1*16 mg.) had a specific 
activity of 204 cpm per mg. A solution of the crystals 
in methanol had a spectrum identical with that of
Table XV. 23. Specific activities, weights and m.p.'s
of 17cc-hydroxyprogesterone after 
successive crystallisations.
Incubation of slices with [4-i^ o] 
progesterone.
Carrier added 750.7 fig.
17a-Hy‘droxyprogesterone 352 pg. ; 12554 cpm per mg.
recovered
Additional carrier added 25.30 mg.
Total material 26.29 mg. ; 240 cpm per mg.
C R Y S T , à L 8 MOTHER LIQUOR
Gryst. Solvent Wt.
(mg.)
M.p. Sp.act. 
(cpm per 
mg.)
Wt. Sp.act 
(mg.) (cpm per 
mg.)
1 Aqueous
methanol
20.01 206-215® 42.2 5.04 1165
2 Ether-
methanol
16.74 204-212* 17.5 3.00 169
3 Chloro­
form-
methanol
12.77 206-212* 14.40 3.15 33.36
Acet. 
+ 4
Aqueous
methanol
9.67 200-214® 15.03 1.71 -
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authentic oestrone;
\ MeOH
\ : 281 mp ( E = 2117)
Max
\ MeOH
\ ; 248-249 mp ( S 232)
Min
The spectrum of a sulphuric acid chromogen of the final 
material (52.6 pg./3 ml, HgSO^ ) was identical with that 
of authentic oestrone (Section II);
Max. mji (O.D.): 229 (0.746) [l]; 299 (0.834);
448 (0,666).
Min. mp (O.D.): 254 (0.202); 371 (0.054).
f) Qestradiol-178 (XX).
Carrier oestradiol-17P was purified by crys­
tallisation from aqueous methanol to yield material of 
m.p. 175-177®.
Of the 1005 pgt oestradiol originally added 
as carrier, 992 pg. of specific activity 4340 cpm 
per mg* was recovered. Additional carrier oestradiol 
(15.35 mg.) was added to the radioactive material 
giving a total weight of 16*64 mg. of determined 
specific activity 254 cpm per mg. After two crystallisa­
tions the specific activity was 6*9 cpm per mg* The 
results are shown in Table IV*24. The mixed m.p, with 
authentic oestradiol (m.p. 175-177®) was 174-178*.
Table IV. 24. Specific activities, weights and m.p,*s
of oestradiol after successive crystal­
lisations .
Incubation of slices with [4-‘*^ c] 
progesterone.
Carrier added 1005 pg.
Oestradiol recovered 992 pg.; 4340 cpm per mg.
Additional carrier added 15«35 mg.
Total material 16.64 mg.; 254 cpm per mg.
OH  T O T A L S  MOTHER LIQUOR
Oryst. Solvent Wt. M.p. Sp.act. Wt. Sp.act.
(mg.) (cpm per (mg.)(cpm per
mg.) mg.)
1 Aqueous 13.04 172.5-175° 15.3 3.43 1350
methanol
Aqueous 9.02 174-178® 6.9
methanol
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The spectrum of a solution of the final material in 
methanol was identical with that of authentic oestradiol:
\ MeOH
X  ; 281 mu ( £  ^1983)
.  ^Max
\ MoOH
X  Î 249 mu ( £ = 248)
 ^^ Min
The spectrum of a sulphuric acid chromogen of the final 
material (25*4 pg*/3 ml. H2SO4) was identical with that 
of authentic oestradiol (Section II):
Max. mp (O.D.): 231 (0*263); 261 (0*157); 302 (0.166);
366 (0.432); 424 (0*419).
Min. mp. (O.D.): 227 (0.257); 264.5 (0*123); 287 (0.155);
320 (0.145); 390 (0.240).
Carrier oestriol was purified by crystallisa­
tions from aqueous methanol to yield material of m.p. 
266-270®.
Of the 980 pg. oestriol originally added as 
carrier, 770 pg. was recovered of specific activity 
20,644 cpm per mg. Additional carrier oestriol 
(15*55 mg.) was added to the radioactive material to 
give a total weight of 16*85 mg*, specific activity 
850 cpm per mg. Two crystallisations from aqueous 
methanol were performed* The specific activity of the 
final material was 22*7 cpm per mg. The results are
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shown In Table IV*25# The mixed m.p* with authentic 
oestriol (m.p. 266-270®) was 262-268®. The spectrum 
of a solution of the final material in methanol was 
identical with that of authentic oestriol;
\ MeOH
X ; 281 mu ( g 2007)
 ^Max
\ MeOH
X  : 248-249 mu (J = 193).
/ \ Min ^
The spectrum of a sulphuric acid chromogen of the final 
material (40.3 pg./3 ml. HgSO^ .) was identical with that 
of authentic oestriol (Section II);
Max. mp (O.D.)s 232 (0.521) [l]} 303 (0.281); 462 (0.200) 
Min. mp (O.D.): 264 (O.I5O); 548 (0.066).
h) Dehydroepiandrosterone (XIII).
Carrier dehydroepiandrosterone was purified 
by crystallisation from aqueous methanol to yield 
material exhibiting m.p. 140-149®.
Of the 1038 pg. carrier dehydroepiandroster- 
one originally added, 695 pg. was recovered of specific 
activity 9447 cpm per mg. Additional carrier dehydro- 
epiandrosterone (18.03 mg.) was added to the radio­
active material to give a total weight of 20.03 mg. 
of specific activity 332 cpm per mg. Two crystallisa­
tions were performed and the specific activity of the 
second crop of crystals was 58.9 cpm per mg. The
Table IV. 25# Spécifie activities, weights and m.p.*s
of oestriol after successive crystal­
lisations.
Incubation of slices with 
progesterone.
Carrier added 9B0 pg.
Oestriol recovered 770 pg.; 20644 cpm per mg.
Additional carrier added 15*55 mg.
Total material 16.85 mg.; 850 cpm per mg.
C R Y S T A L S  MOTHER LIQUOR
Cryst. Solvent Wt. M.p. Sp.act. Wt. Sp.act.
(mg.) (cpm per (mg.) (cpm per
mg.) mg.)
1 Aqueous 9-24 252-264® 68.1 6.95 2156
methanol
2 Aqueous 2.69 263-268° 22.7 6.54 89
methanol
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dehydroepiandrosterone was acetylated and after 
extraction the product was crystallised twice from 
aqueous methanol. The specific activity of the final 
material was 10.8 cpm per mg. free dehydro epiandro- 
sterone. The m.p. of a mixture of the second crop of 
crystals with authentic dehydroepiandrosterone acetate 
(m.p. 163-165j*5®) was 155-162®. The results are shown 
in Table IV.26.
i) Corticosterone (IV).
Carrier corticosterone was purified by crys­
tallisation from aqueous methanol to give material of 
m.p. 170-176®.
Of the 950.6 pg* carrier corticosterone 
originally added, 217 pg. was recovered of specific 
activity 87,800 cpm per mg. Additional carrier 
corticosterone (22.26 mg.) was added to the radioactive 
material, giving a total weight of 22.78 mg. of specific 
activity 929 cpm per mg. Three crystallisations from 
aqueous methanol were performed. The specific activity 
of the third crystallisation was 495 cpm per mg. The 
material was acetylated and crystallised from aqueous 
methanol, the specific activity being 474 cpm per mg. 
free corticosterone (calculated). The results are 
shown in Table IV.27* A solution of the final material 
in methanol exhibited 241-243 mp ( ^ = 16,320).
Table IV. 26. Specific activities, weights and m.p.*s of
dehydroepiandrosterone after successive 
crystallisations, acétylation and 
subsequent crystallisations.
Incubation of slices with [4-1 "*-0] 
progesterone*
C R Y S T A L S  MOTHER LIQUOR
Cryst. Solvent Wt. M.p. Sp.act.* Wt. Sp.act.*
(mg.) (mg.)
1 Aqueous 9.58 129-140° 60.0 7.20 747
methanol
2 Chlore- 6.74 114-130® 58.9 2.56 139
forni-
methanol
Acétylation 6.85 - 62.0
Product
1 Aqueous 4-85 152-160® 24.4 1.66 181
methanol
2 Aqueous
methanol 2.62 155-161® 10.8
Cpm per mg. free dehydroepiandrosterone.
Table IV. 27* Specific activities, weights and m.p.*s
of corticosterone after successive 
crystallisations, acétylation and 
crystallisation.
Incubation of slices with [4-'' 
progesterone.
Carrier added 950.6 pg.
Corticosterone recovered 217 pg.; 87800 cpm per mg.
Additional carrier added 22.26 mg.
Total material 22.78 mg.; 929 cpm per mg.
C R Y S T A L S  MOTHER LIQUOR
Cryst. Solvent V/t. M.p, Sp.act.* Wt. Sp.act.*
(mg.) (mg.)
1 Aqueous 16.51 168-175° 545 3.89 1631
methanol
2 Aqueous 13*68 170-178® 464 2.60 769
methanol
3 Aqueous 11.35 171-178® 495 1.92 532
methanol
Acetate
1 Aqueous 8.08 116-128® 474 4.75 398
methanol
* Cpm per mg. free corticosterone
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The spectrum of a sulphuric acid chromogen of the final 
material (53*9 pg. acetate/3 ml. HgSO^ ) was identical 
with that of authentic corticosterone 21-monoacetate 
(Section II):
Max. mp (O.D.): 239 (0.263); 286 (0.718); 338 (0.218);
376 (0.125); 472 (0.150).
Min. mp (O.D.)î 234 (0.261); 246 (0.259); 322 (0.197);
368 (0.118); 404 (O.O9O).
A second crystallisation of the acetate gave crystals 
of m.p. 137-142® and a mixed m.p. with authentic 
material (m.p* 123-130®) of 124-144®*
j) ll-Deoxycortisol (VII).
Carrier 11-deoxycortisol was purified by 
crystallisation from aqueous methanol to give material 
of m.p. 178-186®.
Of the 887.4 pg* carrier 11-deoxycortisol 
originally added, 418 pg. of specific activity 
276,675 cpm per mg. v;aa recovered. Additional carrier 
(22.12 mg.) was added to the radioactive material to 
give a total weight of 22.87 mg., specific activity 
4674 cpm per mg. The material was crystallised from 
chloroform-methanol to yield material of specific 
activity 4783 cpm per mg. This material was acetylated 
and crystallised three times. The final crystals had 
a specific activity of 3836 cpm per mg. free 11-deoxy- 
cortisol (calculated). The results are shown in
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Table HT.28* A solution of the final material in 
methanol exhibited 241-242 mp (  ^ = 16,900).
The spectrum of a sulphuric acid chromogen of the final 
material (41.4 pg, acetate/3 ml. HgSO^ ) was identical 
with that of authentic 11-deoxycortisol monoacetate 
(Section II);
Max. mp (OiD,); 210 (0*302); 240 (0.310); 287 (0.668);
534 (0.228); 494 (0.095) [l]; 538 
(0.1575).
Min, mp (O.D.): 224 (0.280); 250 (0.262); 323 (0.219);
404 (0.041).
A mixed m.p. with authentic 11-deoxycortisol 21-mono- 
acetate (m.p. 208-214®) was 210-222®.
Table IV, 28. Specific activities, weights and m.p.*s
of 11-deoxycortisol after crystal­
lisation, acétylation and subsequent 
crystallisations•
Incubation of slices with [4-'* *o] 
progesterone.
Carrier added 887*4 pg.
11-Deoxyoortisol recovered 418 pg. ; 276675 cpm per mg.
Additional carrier added 22.12 mg.
Total material 22.87 mg. ; 4674 cpm per mg.
C R Y S T A L S  MOTHER LIQUOR
Gryst. Solvent Wt. M.p. Sp.act.* Wt. Sp.act.*
(mg.) (mg.)
1 Ghloro- 12.15 168-178® 4783 10.68 4390
form- 
methanol
Acetate
1 Aqueous 12.57 210-218® 3555 0.96 3684
methanol
2 Ghloro- 11.04 220-224® 3801 1.14 4668
form-
methanol
3 Aqueous 9.61 214-220® 3836 -
methanol
* Gpm per mg. free 11-deoxycortisol,
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(v) Incubation of liomogenate with progesterone.
In the incubation of the homogenate of the 
adrenal tumour with [4-  ^^o] progesterone, some of the 
steroids were assayed for radioactivity. The results 
are shown in Table IV.29. The radiochemical purity of 
these compounds was not investigated further.
Table IV. 29. Specific activities, weights and m.p.*s
of steroids recovered.
Incubation of homogenate with 
progesterone.
Steroid Carrier
added
(ps*)
Steroid
recovered
(pg.)
Sp.act. 
(cpm per i
Oortisol 997 638 150517
Androstenedione 1026 961 35609
Oestrone 1013 331 9441
Oestradiol-17p 1005 813 1562
Oestriol 980 861 62509
17oc-Hydroxy-
progesterone
751 610 20320
Progesterone 966 841 35826
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4. Discussion
The criterion of radiochemical purity of the 
steroids studied was constancy of specific activity of 
a crystalline compound through successive crystallisa­
tions, the formation of a derivative and subsequent 
crystallisations, or constancy of specific activity 
of a compound after two or more successive paper 
chromatograms. On this basis the following steroids 
isolated from the incubation of feminising adrenal 
tumour slices with progesterone have been
shown to be radiochemically pure : cortisol (VIII),
androstenedione (XIV), 17u-hydroxyprogesterone (VI), 
corticosterone (IV) and 11-deoxycortisol (VII). In the 
same incubation the following steroids could not be 
shown to be radioactive; oestrone (XIX), oestradiol 
(XX), oestriol (XXI) and dehydroepiandrosterone (XIII). 
By the second criterion, progesterone (II) isolated 
from the incubation of tumour slices with [l-^ o^j 
acetate, has been shorn to be radiochemioally pure in 
all three experiments, that is, in the presence of 
AGTH or HMG and also in the absence of any trophic 
hormone. Oortisol (VIII) and androstenedione (XIV) were 
radioactive in the incubation with AOTÏÏ. 17a-Hydroxy- 
progestarone (VI) was radioactive in the experiment 
in which HMG was present.
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By employing the procedure of crystallisa­
tion, formation of a derivative and the subsequent 
crystallisation, rigorous purification of the steroids 
studied in the incubation of tissue slices with 
progesterone has been achieved* In the incubations 
with [1“‘*^ gJ acetate, in most cases too little radio­
activity was found associated with the steroids to 
permit use of the same technique. These steroids were 
therefore further purified by paper chromatography. 
Oestrone (XIX) and oestriol (XXI) were acetylated 
where further study of these two steroids was merited 
by the amount of radioactivity present. However in no 
case were they shown to be radioactive. Androstenedi­
one (XIV), 17a-hydro3cyprogesterone (VI) and progesterone 
(II) were purified by subjecting them to acétylation 
conditions. Unfortunately insufficient 17u-hydroxy- 
progesterone (VI) remained in the experiment with AOTH 
after acétylation conditions (which do not acetylate 
17a-hydroxyprogesterone) to permit further study. 
Oortisol (VIII) was found to be radioactive after the 
incubation of tissue slices with AGTH. However it is 
doubtful whether the radioactivity of this cortisol 
(VIII) is in fact all localised in cortisol (VIII) 
itself. More rigorous purification either by acétyla­
tion as in the incubation with HMG or by crystallisa­
tion as in the incubation without trophic hormone would 
have been preferable.
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The feminising adrenal tumour slices have 
been shown to possess the enzymes necessary for the 
synthesis of at least certain steroids from acetate* 
Progesterone (II) was radioactive in all three experi­
ments in which the radioactive precursor was [l-^  
acetate* In addition, enzymes for the synthesis of 
androstenedione (XTV), lloc-hydroxyprogesterone (VI) 
and possibly oortisol (VIII) were present although the 
evidence for this was obtained only when trophic 
hormones were present. The data obtained in this study 
do^ not permit the suggestion of a mechanism of action 
of the trophic hormones. The minimum incorporation of 
[l-iacetate into progesterone (II) in the presence 
of AGTH, HMG and with no trophic hormone was 0.0011%, 
0,000X8% and 0*00028% respectively. Thus AOTH increased 
the conversion of acetate to progesterone (II) by a 
factor of 6.1 whereas M G  increased it by a factor of 
1.55. At this point the response to AOTH infusion of 
the patient from whom this tumour was obtained should 
be considered* The level of plasma 17-hydroxysteroids 
showed only a slight response to AGTH infusion, suggest­
ing either that the tumour is not responsive to stimula­
tion by exogenous AGTH or that it is already under 
maximum stimulation. The latter is an unlikely occur­
rence since the above normal concentration of circulat­
ing 17**hydroxysteroids would normally depress AGTH out­
put. In the in vitro studies it has been shown that 
AGTH can stimulate activity, at least of the synthesis
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of progesterone (II) from acetate•
Ihe presence of enzymes for the subsequent 
hydroxylation of progesterone (II) have been clearly 
demonstrated in the studies with [4-. 1 *0] progesterone,.
The minimum conversion of progesterone (II) to 17a- 
hydroxyprogesterone (VI) was 0*022%* Subsequent 
hydroxylations at 0-21 followed by that at 0-11 yielded 
ll-deoxyoortisol (VII) (7.8% minimum conversion from 
progesterone (II)) and cortisol (VIII) (2.3% minimum 
conversion from progesterone (II)) respectively- 
Hydroxylations at 0-21 and 0-11 were also shown by the 
presence of radioactive corticosterone (IV) (2*0% minimum 
conversion). The high rate of synthesis of 11-deoxy- 
cortisol (VII) compared with that of cortisol (VIII) is 
interesting* Ho study of the deoxycorticosterone (III) 
in these experiments was made, the activity of which 
might have shed some light on the problem of the activ­
ity of 113-hydroxylase in this tumour* Whether the high 
activity of 11-deoxyoortisol (VII) found in vitro is of 
significance clinically is not known.
It has been clearly shown that the tumour 
possesses enzymes for the synthesis of androstenedione 
(XIV) from progesterone (II)* The minimum conversion 
was 0.48%* The finding of no radioactivity in dehydro- 
epiandrosterone (XIII) is not surprising as it has been 
shown that dehydroepiandrosterone (XIII) is derived 
directly from pregnenolone (XI), rather than by a path­
way involving progesterone (II) (Goldstein et al., 1958).
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Ho synthesis of oestrogens by the tumour 
slices could be demonstratedè This result is in con­
trast to the evidence presented by Baggett and his co­
workers (1959) who demonstrated the in vitro conver­
sion of testosterone (XVI) to oestrone (XIX)
and oestradiol-173 (XX) but not to oestriol (XXI) by 
slices of a feminising adrenal carcinoma from a 66- 
year-old male. The hypothesis that the tumour rather 
than another tissue synthesises the large amount of 
oestrogen, as evidenced by the high urinary values, is 
supported by the identifieation of oestrone (XIX) in 
a feminising adrenal carcinoma (RomaneH i , et al. % 
i960). The dramatic fall in urinary oestrogens 
follov/ing extirpation of the tumour also supports 
this liypothesis. One explanation of the failure to 
demonstrate oestrogen biosynthesis in the present 
study is the small weight of tissue (5.1-5.7 g.) used 
in the incubations relative to the weight of the total 
tumour (1100 g.).
The pathway of oestrogen biosynthesis has been 
shown to exist in this tumour as far as the 0-19 
steroid, androstenedione (XIV). It is possible that 
if a portion of the tumour had been incubated with 
1♦O-androstenedione (XIV) of higher specific activity 
than that isolated, or with ^*0-testosterone (XIV), 
radioactive oestrogens would have been isolated.
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Seotion V : Bisoussion
The purpose of the present research was to 
study steroid hormone biosynthesis in pathological 
tissues using an in vitro technique. Such techniques 
permit close control of the experimental conditions, 
using tissue which is isolated from the influence of 
other organs, and thus allowing comparisons to be made 
from one experiment to another.
The in vitro technique which permits an 
organ to function in a manner most closely related to 
that in vivo is the method of organ perfusion. Indeed 
Vogt (1951), using this technique, claims that the out­
put of corticosteroids by the isolated adrenal gland 
of the dog is approximately that of normal unstressed 
dogs* It is interesting also to recall that the first 
elucidation of the pathway of steroid hormone bio­
synthesis was achieved using results obtained from 
perfusion studies of the cow adrenal. (Hechter et al.. 
1951). This technique however demands the whole intact 
tissue, which is not always available in specimens 
from huBian subjects.
Perhaps the most commonly used in vitro 
teclmique in steroid biosynthetic experimentation has 
been that of incubating slices of an endocrine tissue 
in a physiological medium. The media employed usually 
reflect the ionic composition of the blood of the
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animal being studied. In the saline media, no protein 
comparable to that of the naturally circulating plasma 
proteins is present and this represents a considerable 
loss in properties. Another factor contributing to an 
apparent low activity in a tissue may be the mechanical 
difficulties of obtaining tissue slices. At present, 
it is difficult to achieve uniform slices, especially 
with soft tissues. The use of tissue minces is subject 
to this same criticism of difficulty of duplication.
In addition the loss of organ structure, that is the 
juxtaposition of particular cell types^may contribute 
to misleading data.
With homogenates also there is some difficulty 
in the interpretation of data. Inherent in the homo­
genising technique is the destruction of cellular 
structures with subsequent dilution of the cellular 
components. Thus it must be considered that the 
failure to demonstrate enzymic activity may have been 
caused by a failure of concentration, either of the 
concentration of all the necessary cofactors or of the 
concentration of a substrate at the appropriate site 
of action of an enzyme. Differential centrifugation 
of homogenates yields subcellular fractions which, 
although useful in the study of isolated enzymes, are 
subject to the same limitations as homogenates of whole 
tissue and are therefore of restricted use when a 
complex reaction sequence is being studied.
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The in vitro technique most oommonly used in 
the present study has been the incubation of tissue 
slices in a physiological medium* In this way the 
pathological tissues used could be studied without the 
interactions from other tissues prevalent in vivo *
The tissue slice technique was chosen firstly because 
it was hoped that in this way the conditions were more 
nearly comparable to the in vivo state of the tissue 
than was a homogenate. Secondly slices from the same 
tissue could be studied under a variety of conditions, 
an experimental design which could not have been re­
alised with organ perfusion, even had it been possible 
to obtain the whole intact tissue* Only with the 
technique of tissue slice Incubation was it possible 
to study the biosynthesis of steroid hormones by a 
feminising adrenal tumour, from both acetate
and [4-'* ^0] progesterone in the presence of different 
trophic factors, oorticotrophin and human menopausal 
gonadotrophin «
The tissues studied were, first, ovaries 
obtained from women with the Stein-Levemthal syndrome 
and, second, a feminising adrenal tumour from a 59- 
year-old man. The synthesis of radioactive oestrone 
(XIX), oestradiol (XX), testosterone (XVI), 17u-hydroxy- 
progesterone (VI), androstenedione (XIV) and progester­
one (II) from sodium acetate by tissue slices
of Stein-hevônthal ovaries has been demonstrated*
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Using tissue slices of a feminising adrenal tumour, 
the transformation of progesterone to radio­
active cortisol (VIII), androstenedione (XIV), 17a- 
hydroxyprogesterone (VI), oortioosterone (IV) and 
11-deoxycortisol (VII) has been shown. In three other 
inouhations of the same tissue, one in the presence of 
cortiootrophin (AGTH), another in the presence of human 
menopausal gonadotrophin (MG) and the third in the 
absence of any trophic factor, radioactive progesterone 
(II) was synthesised from sodium [l-’*^ c] acetate. In 
the case where AGTH was present both ^^C-cortisol (VIII) 
and 1^ G-androstenedione (XIV) were isolated# Labelled 
17a-hydroxyprogesterone (VI) was isolated from the in­
cubation mixture which had contained HMG. Discussion of 
the significance of these results has already been in­
cluded in Sections III and IV respectively. The results 
are in agreement with the concept of the same general 
pattern of steroid hormone biosynthesis in all steroido­
genic endocrine tissues outlined in Section I*
However, in conclusion, the significance of 
results obtained from in vitro studies of pathological 
tissues should be examined. In congenital adrenal 
hyperplasia there is a defect in the 0-21 hydroxylating 
system which produces cortisol (VIII) from 17a-hydroxy- 
progesterone (Vl) via 11-deoxycortisol (VII) (Dorfman, 
1955; Bongiovanni, 1958) and sometimes in the C-11 
hydroxylating system (Bongiovanni and Eberlein, 1956).
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Incubation studies in vitro (Bongiovanni, 1958;
O’Donnell et al.» I960) have demonstrated a predominance 
of the llcc-hydroxylase system in this type of adrenal 
tissue. This observation is in agreement with the re­
port that excessive amounts of pregnane-5cc:17ai20a-triol 
(XXIX), the main degradation product of the 17a-hydroxy- 
progesterone (VI), were found in the urine of patients 
with this syndrome. (Pukushima and Gallagher, 1957).
Thus the in vitro activity of the adrenal offers a 
solution of the in vivo biochemical manifestations of 
the disorder.
In this way, an in vitro technique may make 
apparent an enzyme deficiency in the tissue being studied, 
However in such a complex system as the endocrine 
glands with their central control in the region of the 
hypothalamus, via the anterior pituitary, theoretically 
an endocrine disorder may result from an upset of the 
endocrine balance at any stage in the system. As an 
example of such interaction, clinical hypoadrenalism 
is present in both Simmond^s disease and Addison’s 
disease. In Simmonds*s disease the lack of output of 
steroid hormones by the adrenals is due to a lack of 
stimulation by cortiootrophin, produced by the pitui­
tary gland* In Addison’s disease on the other hand, 
the adrenals fail to respond to stimulation.
It must be concluded therefore that data 
regarding the biosynthesis of steroid hormones by
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pathological tissues using an in vitro technique should 
he interpreted with caution, especially when attempting 
to extrapolate to in vivo conditions* However an ex­
tensive comparison of results obtained from well- 
defined in vitro studies of both abnormal and normal 
tissues would provide data which might clarify somewhat 
the problem of the causes of endocrine disorders*
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Section VI : Summary
I. Slices of St8in-Levanthal ovaries were incubated 
with sodium jjl-’ acetate.
II. Slices of a feminising adrenal tumour were
incubated with [4-’ 4-c] progesterone. Slices of 
the same tissue were incubated with sodium [l-’ 
acetate in the presence of cortiootrophin, human 
menopausal gonadotrophin, and in the absence of 
any trophic factor.
III. The radioactive steroids elaborated by these 
tissues were studied using reverse Isotope 
dilution techniques and purified by paper chro­
matography and crystallisation to constant specific 
activity., The steroids were further purified by 
the formation of derivatives and the subsequent 
hydrolysis of these derivatives where this was 
possible.
IV. The biosynthesis from acetate by slices
of Stein-Levanthal ovaries of the following 
steroids was established: oestrone (XIX),
oestradiol (XX), testosterone (XVI), 17a-hydroxy- 
progesterone (VI), androstenedione (XIV) and 
progesterone (II).
V. The conversion of [4-'*^ oJ progesterone by slices 
of a feminising adrenal tumour to the following 
steroids was established: cortisol (VIII),
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androstenedione (XIV), 1?a-hydroxyprogesterone
(VI), corticosterone (IV) and 11-deoxycortisol
(VII). Proof has been given for the synthesis 
of ’^ 0-progesterone from [l-’*o] acetate by 
slices of this tissue incubated in the presence 
of cortiootrophin (AOTH), human menopausal 
gonadotrophin (MG) , and in the absence of any 
trophic factor. Prom the incubation in which 
AOTH was present, ’^ 0-cortisol (VIII) and
’^ 0-androstenedione were isolated. Prom the 
incubation in which HMG was present, ’+0-17a- 
hydroxyprogesterone (VI) was isolated.
VI. The significance of these results has been dis­
cussed in relation to the tissue under study and 
also to a possible correlation with in vivo 
conditions.
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Section VIII : Steroids momenclature and trivial name#
I Cholesterol
HO
II Pregn-4-ene-'3 î20-dione 
(progesterone)
CH.I '
CO
III 21-H3rdro3C7pregn-4*ene-5 î20-dione 
(deoxycorticosterone)
OHgOH
CO
91
IV 11(3 ; 21-dihydx*oxyp3?egii-4-“ene“5 :20-dione
(oortioosterone)
OH 2 OH 
GO
HO
0
IVb 21-h3rdroxypregn-4-ene-5:11:20-trione
(11-deiiydrocorticosterone)
OH 2 OH
I
GO
0
V lip ;21«dihydroxy-5:20-dioxopregn-4-en-~18-al
(aldosterone)
o GO
HO
0
VI 17a-H7droxypregn«4’“ene-"3:20-dione 
(17 a-hydroxypro gesterone)
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OH-
I ■
CO
k-OH
VÏI 17a : 21-Di]iydroxypregn-4-ene'-3 :20-dione
(11-deoxycortisol)
GHpOHI ^
00
_0H
0
lip : 17a : 21-Trihydroxypregn-4-ene-3:20-dione
(cortisol)
OH 2 OHI
GO
HO -OH
0
93.
IX 17a :21-dihydroxypregn-4-ene-3:11:20-trione
(cortisone)
CHpOH
I
GO
X ll|3-Hydroxypregn-4-ene-5:20-dione 
(11p-hydroxypro ge st erone)
CH. 
! ■ 
GO
HO
XI 5P-Hydroxypregn-5"en-20-one 
(pregnenolone)
CH.
i ■
GO
HO
94*
XII 20|3-*Hydroxyôhole sterol
GH3
HO-G— CgHia
HO
XIÏl 5 p-'Hydroxyandrost-5-en-17-one 
(dehydroepiandrosterone)
0
HO'
XIV Androst-4'-ene-3 !l7*-dione 
(androstenedione)
0
0
95.
TV llp-*Hydroxyaîidrost-4-eiLe-3 ïlT-dione 
(11p^hydroxyandro st enedi one)
ZVI 17P-Hydroxyandrost"4-*eii-3-*one 
(testosterone)
OH
G
XVII 5 P ; 17a-Dihydî?oxypregn-5"en-20*one 
(17 oc-Hydroxypre gneno lone )
CH. ! ■
00
OH
HO
96*
XTlfl Androst-4'^ ene'-*;5:11 ; 17*"trione 
(adreno st evone)
0
XIX 3*-Hydr05Qroestra-l s 5 5 5 ( 10)*-t3i‘ien*-17*-'One
(oestrono)
XX Ôestra-1:3:5 (10)**triene^ 3 * l?|3-*diol 
( oestradiol^l? f3)
OH
HO
97.
XXI Oestra-lî3:5(10)-triene-5 îl6aîl7P-triol 
(oestriol)
OH
OH
HO
XXII 19-HortestosterorLe
OH
0
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A Study on Steroid Hormone Biosynthesis 
by Jean Gray Birnie, B.Sc*
In recent years the pathways of steroid 
hormone biosynthesis have received a great deal of 
attention. An increasing amount of evidence for the 
concept of a general pathway of steroid hormone bio­
synthesis in all steroidogenic endocrine tissues has 
accumulated from the published results of studies in 
various tissues of a number of species* The object 
of the present study was to investigate the steroido­
genic capacity of two types of pathological tissue, 
namely, ovaries from women with the Stein-Levanthal 
syndrome and a feminising adrenal tumour from a 39- 
year- old man.
Slices of these tissues, obtained from 
patients at surgery, were incubated at 37® C for 3 
hours with sodium [l-'*^ oJ acetate or pro­
gesterone in Krebs-Ringer phosphate buffer, pH 7*4, 
supplemented with glucose, fumarate and nicotinamide. 
The incorporation of the isotope into various steroid 
hormones was studied by means of the reverse isotope 
dilution technique. Steroids were purified either 
by paper chromatography or by crystallisation and 
preparation of derivatives. The criterion of radio­
chemical purity was taken as constancy of specific
2.
activity measured after two successive paper chromato­
grams or crystallisations.
It has been found that, when slices of Stein- 
Levanthal ovaries were incubated with i^0-acetate, the 
isotope was incorporated into oestrone, oestradiol 
and a substance which was similar to, but not identical 
with, oestriol. In addition, it has been shown that 
this ovarian tissue synthesised progesterone, andro- 
stenedione, testosterone and 17c-hydroxyprogesterone 
from ’^ 0-acetate. The presence of human menopausal 
gonadotrophin in the incubation medium decreased the 
amount of ^^ 0-acetate incorporated into androstenedione 
and increased the amount incorporated into progesterone, 
testosterone and 17çt-hydroxyprogesterone.
It has been established that when slices of 
the feminising adrenal tumour were incubated, ’^ 0- 
progesterone was converted to cortisol, corticosterone, 
11-deoxyoortisol, 17ot-hydroxyprogesterone and andro­
stenedione. In addition, the biosynthesis of ’'^O- 
progesterone from ‘^♦G-acetate by this tumour tissue 
has been demonstrated. The presence of corticotrophin 
and human menopausal gonadotrophin in the incubation 
medium increased this incorporation of  ^^ 0-acetate into 
progesterone by factors of 6.1 and 1.55 respectively.
It has been shown that, when corticotrophin was present, 
androstenedione and cortisol were synthesised from 
’♦G-acetate. In the incubation in which human
3.
menopausal gonadotrophin was included, 17(%-hydroxy- 
progesterone was synthesised* In no incubation could 
the biosynthesis of oestrone, oestradiol or oestriol 
by the adrenal tumour be demonstrated*
The foregoing results agree with the concept 
of a general pathway of steroid hormone biosynthesis 
in all steroidogenic tissues* Experiments of this type 
may illuminate an enzyme deficiency within a pathological 
tissue and in this way, elucidate the clinical biochemi­
cal manifestations associated with the resulting 
disease*
